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ABSTRACT
Recent findings of brown adipocytes and brown-like or beige adipocytes, capable
of dissipating energy as heat, in adult humans have promised new hope for obesity
treatment and prevention. Understanding of the regulation of brown and beige
adipocytes will provide novel strategies to reach the goal. Pattern recognition receptors
(PRR) are responsible for inflammation in adipose tissue, which leads to adipose
dysfunction and obesity associated chronic diseases. It has been shown that PRR
activation induces inflammation, leading to insulin resistance in white adipocytes and
white adipose tissue (WAT). However, the roles of PRR activation in brown adipocytes
and brown adipose tissue (BAT) have not been studied. In addition, in vitro and in vivo
studies have shown that bioactive food components can contribute to obesity
prevention; however, very few bioactive food components have been studied for their
beneficial effects in promoting development and function of brown and beige
adipocytes.
This dissertation reports that (1) mRNA of PRRs and inflammatory
cytokines/chemokines are upregulated in the BAT of both diet induced obesity mice
model and ob/ob mice model; (2) activation of PRRs induces activation of NF-κB and
MAPK signaling pathways, leading to upregulation of the proinflammatory genes, MCP1, IL-6, RANTES, and TNF-α, in mature brown adipocytes; (3) activation of PRRs
suppresses UCP-1 expression, leading to decreased mitochondrial respiration and
thermogenesis in mature brown adipocytes; (4) chronic activation of PRRs reduces
adipogenesis and suppresses expression of brown-specific genes in both classic brown
adipocytes and multipotent stem cells. This dissertation further demonstrates that
v

naringenin, a flavanone mainly found in citrus fruits, enhances thermogenic activation in
isoproterenol-stimulated 3T3-L1 adipocytes through PKA/p38 MAPK pathways.
The results suggest that PRR-mediated inflammation in brown adipocytes may
be a potential target for regulating BAT development and function for obesity treatment
and prevention. Dietary bioactive compounds, such as naringenin, could be beneficial in
promoting functional BAT, thereby contributing to energy expenditure.
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INTRODUCTION
Obesity is a major health concern in the US: over 70% of adults are overweight
(BMI of 25 to 29.9) or obese (BMI of 30 and over). Obesity leads to metabolic diseases
including heart disease, stroke, and diabetes (National Institutes of Health, 2011).
Obesity is caused by excess of energy intake that exceeds energy expenditure. Food is
a major source of energy intake, while physical activity and basic metabolism rate are
the major contributors to energy expenditure (Church et al., 2011; Hill, Wyatt, & Peters,
2012). Physiologically, obesity is defined as excessive fat accumulation mostly in
adipose tissue; hence, excess of adipose tissue is a hallmark of obesity. White adipose
tissue (WAT) and brown adipose tissue (BAT) are the main types of adipose tissue in
humans. WAT stores excess energy in the form of triglycerides whereas BAT dissipates
energy through non-shivering thermogenesis, or heat production (Y. H. Lee, Mottillo, &
Granneman, 2014).
It is well recognized that obesity is associated with inflammation in adipose
tissue, characterized by elevated proinflammatory cytokine/chemokine expression and
infiltration of immune cells and that adipose inflammation is the starting point for
dysfunction of adipose tissue and lipid metabolism, leading to obesity associated
chronic diseases (Eto et al., 2009). It has been demonstrated that pattern recognition
receptors (PRRs), including Toll-like receptors (TLRs) and Nucleotide-oligomerization
domain-containing protein-like receptors (NLRs), play important roles in innate immune
response and mediating adipose inflammation (Jin, Henao-Mejia, & Flavell, 2013;
Takeuchi & Akira 2010). PRRs are responsible for the sensing of invading microbial
pathogens leading to distinct inflammatory and immune responses in the host cells.
1

In contrast to WAT’s function for energy storage, BAT is a specialized tissue
whose function is to produce heat through nonshivering thermogenesis via the functions
of uncoupling protein 1 (UCP-1). UCP-1 proteins are localized in the inner membrane of
brown adipocyte mitochondria to uncouple ATP synthesis from respiration. Newborn
infants have BAT and that BAT quickly regresses following birth. However, new
evidence from positron emission tomography/computed tomography scanning has
revealed symmetrical fat depots in adults that have classical BAT features (Cypess et
al. 2009; van Marken Lichtenbelt et al. 2009). Therefore, BAT has become a novel
target for obesity treatment and prevention. While it has been reported that activation of
PRRs increases inflammatory response and insulin resistance in WAT and white
adipocytes (Pierre et al., 2013; Song et al., 2006; Zhao et al. 2011), the role of PRRmediated inflammation in regulating the function of BAT and brown adipocytes has not
been studied.
Recent evidence has also reported inducible brown-like adipocytes, also known
as beige adipocytes, in WAT in animals and humans (Giralt & Villarroya, 2013; Lo &
Sun, 2013; Rosenwald & Wolfrum, 2014). When exposed to cold temperature, hormonal
stimuli (e.g. irisin and T3) (Obregon, 2014a; Zhang et al., 2014), or pharmacological
treatment (e.g. rosiglitazone, bone morphogenetic protein, and isoproterenol) (Elsen et
al., 2014; Obregon, 2014b; J. Wu et al., 2012), beige adipocytes can adopt a brown
adipocyte phenotype (i.e., browning) with increased UCP-1 expression, contributing to
thermogenesis and energy expenditure. Identification and characterization of dietary
bioactive components to increase the development and functions of both classical
brown and beige adipocytes hold great promise for obesity treatment and prevention.
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Therefore, this dissertation begins with an overview of the role of inflammation,
functions of adipose tissue, and genetic, pharmacological, and nutritional regulators for
BAT development and browning functions. The chapter II focuses on the role of acute
PRR activation in inflammation and mitochondrial respiration in mature brown
adipocytes. The chapter III focuses on the role of chronic PPR activation in brown
adipogenesis using two brown adipogenesis cellular models: immortalized brown preadipocytes and multipotent mesodermal stem cells. The chapter IV reports the effects of
naringenin, a citrus flavanone, on browning and thermogenic function in 3T3-L1
adipocytes.
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CHAPTER I
LITERATURE REVIEW
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1.1 Obesity and adipose tissue
1.1.1 Obesity and metabolic disease
Obesity has become a growing epidemic worldwide over the past few decades
(Keating, Backholer, & Peeters, 2014; Ng et al., 2014; Seidell & Halberstadt, 2015).
Currently, almost 70% of adults in the US are overweight and 25% are obese, with rates
having almost tripled in the last two decades (Ezzati, Martin, Skjold, Vander Hoorn, &
Murray, 2006). Obesity is caused by a positive energy balance when energy intake
exceeds energy expenditure over a given period of time (Vandevijvere, Chow, Hall,
Umali, & Swinburn, 2015). Food intake is a major source of energy intake, while
physical activity and basic metabolism rate are the major contributors to energy
expenditure (Church et al., 2011; Hill, Wyatt, & Peters, 2012). However, our
understanding of the mechanisms by which the body acts to achieve and maintain
energy balance is incomplete (Hill et al., 2012).
In humans, energy is spent in several forms. Energy is expended to support
basal metabolism needs for the normal functioning of cells and organs at rest. It is also
expended to absorb and metabolize consumed food, which is referring to the thermic
effect of food. Energy is also consumed through physical activity (Hill et al., 2012;
Joosen & Westerterp, 2006) and dissipated for adaptive thermogenesis in response to
environmental changes, such as cold temperature and diet (Tseng, Cypess, & Kahn,
2010). There are three types of thermogenesis: shivering thermogenesis, non-shivering,
and diet-induced heat dissipation (Cannon & Nedergaard, 2011; Tseng et al., 2010).
Shivering thermogenesis is induced in skeletal muscles and is a process in which heat
is generated by shivering to stay warm (Tseng et al., 2010; van den Berg, van Marken
5

Lichtenbelt, van Dijk, & Schrauwen, 2011). Non-shivering thermogenesis occurs in the
brown adipose tissue (BAT) upon certain stimuli such as cold exposure (Mineo, Cassell,
Roberts, & Schaeffer, 2012; Nguyen et al., 2011; Sammons & Price, 2014; Teulier et al.,
2010; van der Lans et al., 2013; van Marken Lichtenbelt & Schrauwen, 2011), while
overfeeding could trigger the diet-induced thermogenesis propensity of brown fat to
achieve energy balance (Shingo Kajimura & Saito, 2014; Tseng et al., 2010).
Obesity is a well-known risk factor that leads to metabolic disorder, including
diabetes (Shigetoh et al., 2009), hypertension (Re, 2009), cardiovascular diseases
(Apovian & Gokce, 2012), and cancers (Basen-Engquist & Chang, 2011). Metabolic
disorder has at least three of the following features: abdominal obesity (waist
circumference > 40 inches in males or 35 inches in females), hypertriglyceridemia (≥
150 mg/dL), low HDL cholesterol (< 40 mg/dL in men or < 50 mg/dL in women),
hypertension (≥ 130/85 or on antihypertensive medication), or elevated fasting glucose
(≥ 110 mg/dL or on medication for diabetes). Insulin resistance has been suggested as
the primary factor responsible and precedes other aspects of metabolic disorder
(National Institutes of Health, 2011).
1.1.2 Anatomy of adipose tissue: WAT and BAT
There are two major types of adipose tissue: white adipose tissue (WAT) and
BAT, which contribute to energy balance in humans (Y. H. Lee, Mottillo, & Granneman,
2014). WAT exists throughout the body and has different functions depending on the
anatomical site. WAT is mainly found in two places: visceral adipose tissue and
subcutaneous adipose tissue. Visceral adipose tissue is predominantly located around
the inner organs, such as the intestines, stomach, spleen, kidney, gonad, uterus,
6

ovaries, epididymis, testis, and pericardial. Subcutaneous adipose tissue is located
around the abdomen, hips, thighs, legs, and other lower body parts. The function of
subcutaneous adipose tissue is protecting organs in the body and lipid accumulation
(Bjø rndal, Burri, Staalesen, Skorve, & Berge, 2011; Gesta, Tseng, & Kahn, 2007).
Visceral adipose tissue is more associated with metabolic issues such as insulin
resistance than subcutaneous adipose tissue. In contrast, BAT exists in a distinct
location depending on species (only higher mammals) and age (Gesta et al., 2007;
Saely, Geiger, & Drexel, 2012).
BAT is most abundant in the interscapular region and is present throughout life in
rodents. In humans, BAT is located in the interscapular region and found in the cervical,
paravertebral, supraclavicular, periadrenal, suprarenal, and subscapular areas in
infants. However, it is remarkably reduced with age, leading to a remarkable absence in
adults (Cinti, 2001, 2007; Gesta et al., 2007; Lanthier & Leclercq, 2014; Y. H. Lee et al.,
2014; Saely et al., 2012; Vosselman, van Marken Lichtenbelt, & Schrauwen, 2013).
Infants do not have enough muscles for shivering when exposed to cold temperatures,
making heat production from BAT essential for maintaining temperature homeostasis
(Devlin, 2015; Hu, Yin, et al., 2013; Zafrir, 2013). However, recent studies have
detected BAT in adults using 2-deoxy-2-(18F)fluoro-D-glucose integrated with Positron
Emission Tomography associated with Computed Tomography (18F-FDG PET/CT).
FDG is the most common radiotracer and makes fluorine attach to glucose. Intravenous
FDG and PET/CT scan images identify BAT spots through the anatomic localization of
radiotracer uptake (Holstila et al., 2013; Hu, Perkins, Chia, & Gilsanz, 2013; J. W. Park
et al., 2015).
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The amount of active BAT in adult humans is associated with temperature,
stress, age, and obesity (Cereijo, Giralt, & Villarroya, 2015; De Matteis et al., 2013;
Saely et al., 2012; Virtanen, van Marken Lichtenbelt, & Nuutila, 2013; Vosselman et al.,
2013; Zafrir, 2013). Catecholamine secreted in response to stress is also correlated with
BAT activity. Pheochromocytoma patients have six times higher plasma metanephrine
than normal patients and more BAT measured by 18F-FDG PET/CT, while their body
weight, cholesterol, blood glucose, triglyceride, and WAT show no significant difference
(Q. Wang et al., 2011). BAT is more activated when exposed to cold temperature (16°C)
compared to warm temperature (22°C) in lean male adults (body mass index (BMI) of
23 or lower). In addition, more BAT is detected in lean male adults in PET/CT scan
images than obese adult males when exposed to cold temperature (van Marken
Lichtenbelt et al., 2009). This also extends to in vivo studies that show lean mice have
more BAT in 18F-FDG PET images than obese imprinting control region (ICR) mice fed
a high-fat diet (70% fat) and streptozocin-induced diabetic mice (C. Wu et al., 2014).
1.1.3 Functions of adipose tissue: WAT and BAT
The main functions of WAT are lipid synthesis and energy storage (Pavelka,
Roth, Pavelka, & Roth, 2010). Excess energy in the form of triglycerides stored in WAT
is hydrolyzed to free fatty acids and then released into the body’s circulation to be used
as energy for the organs (Giralt & Villarroya, 2013; Saely et al., 2012). This process of
lipolysis plays important roles in energy metabolism, such as energy homeostasis in the
human body. Besides energy storage and release, WAT also acts as an important
endocrine organ as it expresses and secretes several polypeptide hormones known as
adipokines, including leptin and adiponectin (Trayhurn & Beattle, 2001).
8

Increased serum leptin levels and decreased serum adiponectin levels are
associated with higher obesity rates (Ricci & Bevilacqua, 2012). A higher ratio of leptin
to adiponectin is observed in Italian young adults with severe obesity and metabolic
phenotypes (insulin resistance and higher plasma lipid levels) than normal obese Italian
young adults (Labruna et al., 2011). Leptin was first identified as an adipocyte hormone
and plays an important role in controlling appetite, leading to the regulation of energy
homeostasis in the body (Siegrist-Kaiser et al., 1997). Serum leptin level and body
weight are increased in C57BL/6 mice fed a high-fat diet (60% fat) compared to regular
chow-fed lean mice (Rhodes et al., 2013). Leptin (10 nM) significantly increases glycerol
release, leading to lipolysis, in the WAT fat pad of Sprague-Dawley rats (Siegrist-Kaiser
et al., 1997). Leptin-deficient ob/ob mice (C57BL/6J) have higher body weight and blood
glucose level than lean mice (C57BL/6) (Drel et al., 2006). Acute physiological leptin
(50-200 ng/h implanted tube by surgery) in leptin-deficient ob/ob mice dose-dependently
reduces body weight and significantly increases plasma leptin level (Morton et al.,
2011). Adiponectin, known as adipoQ, is also a key regulator of energy metabolism
(Bjursell et al., 2007; Fang & Sweeney, 2006; Lafontan & Viguerie, 2006). Adiponectin
is responsible for insulin sensitivity (Kadowaki et al., 2006; Maeda et al., 2002) and fatty
acid oxidation (Yamauchi et al., 2002; Yoon et al., 2006). The levels of adiponectin and
insulin resistance are significantly decreased in humans with obesity (Abdelgadir,
Karlsson, Berglund, & Berne, 2013; Yadav, Kataria, Saini, & Yadav, 2013). Adiponectin
macrophage-specific transgenic mice encoding human adiponectin gene and fed a
high-fat diet have less tumor necrosis factor (TNF)-α and monocyte chemotactic protein
(MCP)-1 mRNA expression in macrophage, skeletal muscle, and adipose tissue. In
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addition, glucose tolerance and insulin tolerance are decreased in transgenic mice fed a
high-fat diet compared to lean mice (Luo et al., 2010).
In contrast, the key function of BAT is to promote energy expenditure (Y. H. Lee
et al., 2014). BAT is primarily responsible for energy oxidation to produce heat via
uncoupling respiration to maintain the body’s temperature (McMillan & White, 2015;
Saely et al., 2012; van Marken Lichtenbelt & Schrauwen, 2011; Virtanen et al., 2013). In
WAT, once the sympathetic nervous system (SNS) is activated, a neurotransmitter such
as noradrenaline is released. The neurotransmitter then binds to beta-adrenergic
receptors (β-AR) on the plasma membrane of adipocytes, leading to adenylyl cyclase
activation. This in turn promotes the conversion of adenosine triphosphate (ATP) into
the second messenger cyclic adenosine monophosphate (cyclic AMP or cAMP),
activates protein kinase A (PKA), and subsequently releases free fatty acid through the
lipolysis process. Free fatty acid released from lipid droplets is oxidized through the
Krebs cycle in the mitochondria, and the intermediated electrons from the Krebs cycle
flow through the electron transport chain (ETC) and produce a proton gradient to
generate energy through ATP synthesis (Azzu & Brand, 2010; Brondani et al., 2012). In
BAT, however, proton leak is produced from uncoupling protein-1 (UCP-1) on the
mitochondrial inner membrane to generate heat instead of cellular respiration ATP
synthesis (Azzu & Brand, 2010; Brondani et al., 2012; Cohen & Spiegelman, 2015;
Harms & Seale, 2013). Saturated purine nucleotides (GDP) inhibit UCP-1 activation and
fatty acids (palmitate) reactivate UCP-1. Heat generation via UCP-1 protein in BAT
uncouples the respiratory chain, allowing fatty acid to be oxidized with low ATP
production. The function of UCP-1 in BAT is discussed further in a later section.
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Understanding the physiological and pathological mechanisms for reducing WAT
functions and developing BAT functions can be important for preventing obesity. The
key regulators of BAT development are discussed in a later section.

1.2 Chronic inflammation in obesity
1.2.1 Adipose inflammation in obesity
Inflammation in adipose tissue has been generally recognized as a primary
cause of obesity and obesity-associated diseases (Balistreri, Caruso, & Candore, 2010).
Adipose tissue comprises many kinds of cell types, including adipocytes, vascular cells,
fibroblasts, and macrophages (Eto et al., 2009). Research has detected the infiltration of
macrophages in adipose tissue of obese mice (Nishimura, Manabe, Nagasaki, et al.,
2009). Infiltration of F4/80+ cluster of differentiation (CD)11b+ macrophages has also
been demonstrated to be significantly higher in obese C57BL/6J mice fed a high-fat diet
high fat diet and leptin-deficient ob/ob mice compared to regular chow-fed counterparts
(Nishimura, Manabe, Nagasaki, et al., 2009). Macrophages in adipose tissue are
responsible for inflammatory-specific gene expression, such as interleukin (IL)-6, TNFα, transforming growth factor (TGF)-β, MCP-1, and chemotactic cytokine ligand 5 (CCL5
or RANTES) (Balistreri et al., 2010; Braunersreuther, Viviani, Mach, & Montecucco,
2012; Fantuzzi, 2005; Gilbert & Slingerland, 2013). Mice intraperitoneally injected with
serum free macrophage-derived condition medium (0.1 mL/10 g) have significantly
higher mRNA expression of TNF-α, IL-6, and MCP-1 in adipose tissue compared to
saline-injected mice (Jiang et al., 2014). Ponies with metabolic diseases have 10-fold
higher resting insulin level, serum TNF-α and IL-6 concentration, and body weight with
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increased macrophage infiltration and TNF-α and IL-6 expression in adipose tissue
compared to healthy ponies (Basinska, Marycz, Śmieszek, & Nicpoń, 2015).
TNF-α is secreted from adipocytes through activation of the mitogen-activated
protein kinase (MAPK) and nuclear factor kappa B (NF-κB) signaling pathways, leading
to the enhanced expression of inflammatory-related genes (X. Chen, Xun, Chen, &
Wang, 2009; Gountopoulou, Leondaritis, Galanopoulou, & Mavri-Vavayanni, 2008).
TNF-α is an especially important factor for adipose tissue because it regulates insulin
resistance through insulin receptor signaling, and its upregulation leads to obesity and
diabetes. A clinical study has indicated that serum TNF-α is upregulated in
overweight/obese humans (13 males and 15 females with BMI of 27 or more) compared
to lean humans (7 males and 8 females with BMI of 25 or less). In addition, expression
of TNF-α in both subcutaneous and visceral adipose tissues is significantly increased (3
folds) in obese humans compared to lean humans (Winkler et al., 2003). TNF-α-infused
male Syrian golden hamsters (0.5 μg/kg/h for 4 hours) have lower phosphorylation of
insulin receptor (IR)-β and IR substrate-1 (IRS-1) in primary hepatocytes compared to
control hamsters (Qin, Anderson, & Adeli, 2008), indicating TNF-α-induced hepatic
insulin resistance.
As with TNF-α, IL-6 also plays an important role in inflammation in adipose tissue
(Carlsen et al., 2009; Eder, Baffy, Falus, & Fulop, 2009). It has been shown that higher
adiposity, body fat mass, waist circumference, and fatty acid levels increase serum IL-6
level in human studies (Morisset, Huot, Légaré, & Tchernof, 2008; Rexrode, Pradhan,
Manson, Buring, & Ridker, 2003). Women (773 aged 50s) who have higher weight, BMI,
body fat mass, and abdominal adipose tissue have higher circulating IL-6 level
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(Morisset et al., 2008). A randomized double-blind study has also shown that higher
serum IL-6 levels are detected in women who have higher BMI and waist/hip ratio
among a total of 48 women (aged 39.6-61.7 and BMI of 17.2-41.3) (Rexrode et al.,
2003).
MCP-1, a chemotactic factor, is significantly enhanced in the plasma of obese
mice and humans (C. Kim et al., 2006; Takahashi et al., 2003). MCP-1 expression in
epididymal WAT and circulating MCP-1 protein level are remarkably increased in
C57BL/6N mice fed a high-fat diet (32.6% fat for 6 months) compared to regular chowfed mice (Takahashi et al., 2003). A clinical study by Kim and associates has
demonstrated that obese subjects (BMI of 30 or above) have higher triglyceride, total
cholesterol, MCP-1, and IL-6 in serum compared to non-obese counterparts (BMI of 20
or less) (C. Kim et al., 2006). The expression of MCP-1 mRNA in WAT and plasma
MCP-1 levels are significantly increased in C57BL/6J obese mice fed a high-fat diet, but
not increased in regular chow-fed mice (Kanda et al., 2006). In addition, macrophage
infiltration and expression of macrophage-related genes, TNF-α, CD68, and F4/80, are
reduced in adipose tissue of MCP-1 knockout C57BL/6J mice (Kanda et al., 2006).
Evidence of the relationship between adipose tissue inflammation and obesity
has been shown in animal and human studies (Nishimura, Manabe, & Nagai, 2009;
Vieira et al., 2009; Wentworth et al., 2010). Humans with obesity or with both obesity
and metabolic diseases have more macrophage infiltration in subcutaneous adipose
tissue compared to lean humans. More macrophage infiltration leads to higher
expression of proinflammatory cytokines, IL-1β, IL-6, and TNF-α (Wentworth et al.,
2010). Furthermore, abnormal adipose function and lipid metabolism in obesity lead to
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inflammation in adipose tissue (Ichimura et al., 2012; Iyer, Fairlie, Prins, Hammock, &
Brown, 2010; Lumeng & Saltiel, 2011). High-fat diet-fed G-protein coupled receptor
(GPR)120 knockout mice have 10% increased body weight compared to high-fat dietfed wild-type mice. Lacking of GPR120 also leads to insulin resistance, resulting in
decreased insulin signaling and increased inflammation in adipose tissue. High-fat dietfed GPR120 knockout mice show impaired glucose metabolism, which is revealed by
increased levels of fasting glucose and blood glucose. Moreover, adipocyte size and
macrophage marker genes, CD11b, CD68 and F4/80, in adipose tissue are increased in
high-fat diet-fed GPR120 knockout mice (Ichimura et al., 2012).
1.2.2 Role of the pattern recognition receptor in adipose inflammation
Lumeng has reviewed the importance of the innate immune response in obesity
(Lumeng, 2013). Adipocytes attacked by foreign microbes recruit inflammatory
macrophages around the damage site of the adipocytes, which secrete inflammatory
cytokine, resulting in insulin resistance (Lumeng, 2013). The innate immune system
recognizes pathogen-associated molecular patterns (PAMPs) via pattern recognition
receptors (PRRs) that play an important role in inflammation and immune response
(Miller et al., 2011; Takeuchi & Akira, 2010; Tang et al., 2011). There are two families of
PPRs: membrane-bound toll-like receptors (TLRs) and cytoplasmic nucleotide
oligomerization domain-like receptors (NLRs) in response to the inflammation of
adipose tissue (J. Y. Lee, Zhao, & Hwang, 2010; Watanabe, Nagai, & Takatsu, 2013).
TLRs are composed of the extracellular leucine-rich repeat (LRR) and the
cytoplasmic toll/interleukin-1 receptor (TIR) domain. There are 10 TLRs identified in
humans, and each TLR recognizes a different ligand. For example, TLR2 and TLR4
14

recognize lipoprotein and lipopolysaccharide (LPS), respectively (Barton & Medzhitov,
2002; S.-J. Kim, Choi, Choi, & Park, 2012; Takeuchi & Akira, 2010). It has been widely
shown that TLR2 and TLR4 are involved in metabolic functions and the inflammatory
response in obesity (Ahmad et al., 2012; Fusaru et al., 2012). Immunohistochemical
reaction results have shown that in lean subjects, TLR2 and TLR4 are expressed only in
CD68 positive immunocompetent cells (which could be lymphocytes and myeloblasts).
However, in obese subjects with BMI of 30 and over, TLRs 2 and 4 are expressed in
three cell types: immunocompetent cells, vessels, and adipose cells. Subjects with
diabesity (obesity and diabetes) have higher TLR2 and TLR4 expression in all three
types of cells than obese subjects (Fusaru et al., 2012). The activation of TLR2 and
TLR4 is mediated by MyD88, which comprises the death domain and TIR domain.
Ahmad et al. have shown that TLR2 and TLR4 mRNA expression in peripheral blood
mononuclear cells is positively correlated with BMI in human subjects
(obese>overweight>lean). TLR2 and TLR4 expression in adipose tissue also increases
in obese subjects (also obese>overweight>lean) (Ahmad et al., 2012).
MyD88 is more highly expressed in peripheral blood mononuclear cells and the
adipose tissue of obese subjects than in lean subjects (Ahmad et al., 2012). MyD88
activates the MAPK and NF-κB pathways that are responsible for inflammatory
response (Kawai & Akira, 2007). LPS (0.25-5 μg/mL for 12-48 hours) increases
expression of TLR4 and proinflammatory cytokines, IL-6 and TNF-α, in primary bone
marrow mesenchymal stem cells isolated from C57BL/6J mice (R.-L. Huang et al.,
2013). Phosphorylation of NF-κB p65 and NF-κB are significantly increased in the LPStreated bone marrow mesenchymal stem cells of wild type mice (C57BL/10 and
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C57BL/6J), but are reduced in TLR4 knockout mice (C57BL/10ScNJ) and MyD88
knockout mice (R.-L. Huang et al., 2013). Fatty acid induces inflammatory response
through TLR4 in adipose tissue in obese mice (Jung & Choi, 2014; Shi et al., 2006;
Song, Kim, Yoon, & Kim, 2006). Free fatty acid induces TNF-α mRNA and IL-6
expression in macrophages and adipocytes isolated from wild-type mice but not in
macrophages isolated from TLR4 knockout mice (C57BL6/J strain). Obese C57BL6/J
mice fed a high fat diet (D12331 from Research Diets Inc. for 16 weeks) and leptindeficient ob/ob mice have higher TLR4 mRNA expression in adipose tissue than regular
chow-fed control mice and wild-type mice, respectively (Shi et al., 2006). 3T3-L1
adipocytes treated with free fatty acid (750 μM for 3 hours), LPS (5 μg/mL for 1 hour),
and TNF-α (5 ng/mL for 1 hour) increase NF-κB activities by 2, 2, and 4-fold,
respectively (Song et al., 2006). Male TLR4 knockout mice fed a high-fat diet (45% fat)
have less body weight, subcutaneous adipose tissue, and visceral adipose tissue than
C57BL/6J wild-type mice (Pierre et al., 2013). Both TLR4 and TLR2 mRNA are highly
expressed in mature 3T3-L1 adipocytes and adipose tissue of high-fat diet-fed
C57BL/6J mice and leptin-deficient ob/ob mice (Purohit et al., 2013; Zhao, Hu, Zhou,
Purohit, & Hwang, 2011). Furthermore, TLR2 is responsible for insulin resistance in
adipocytes. A previous study has shown that expression of IL-6, MCP-1, TLR2, and
TLR4 is increased in 3T3-L1 adipocytes treated either palmitate (0.5 mM) or LPS (10
μg/mL) compared to non-treated cells. 3T3-L1 adipocytes treated with palmitate and
LPS for 48 hours reduce insulin-stimulated 2-deoxyglucose uptake compared to nontreated control cells. Palmitate and LPS also increase NF-κB activation and IL-6, MCP1, TLR2, and TLR4 mRNA expression through JNK pathways in 3T3-L1 adipocytes
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(Davis, Gabler, Walker-Daniels, & Spurlock, 2009). Unlike TLR4 knockout mice, TLR2
knockout mice (C57BL/6J strain) are heavier than wild-type mice. MyD88 and IRS-1
expression is also increased, but insulin sensitivity is decreased in the muscle, liver, and
adipose tissue of TLR2 knockout mice compared to wild-type mice (Caricilli et al.,
2011). On the other hand, Ehses has reported that female TLR2 knockout mice
(C57BL/6J strain) fed a high-fat diet for 20 weeks have improved peripheral insulin
sensitivity than wild-type mice fed a high fat diet, indicating that the lack of TLR2 may
lead to metabolic phenotype. Female TLR2 knockout mice fed a high-fat diet have less
fat weight and MCP-1 mRNA expression in the liver, with no changes of other
inflammatory cytokines in the liver, including IL-6 and TNF-α (Ehses et al., 2010). This
suggests that mice without TLR2 may be protected from insulin resistance when fed a
high fat diet. The different results from Caricilli and Ehses may be explained by the
gender difference (male vs. female) or diet (regular chow vs. high-fat diet).
The NLR family is composed of the central nucleotide binding domain and the Cterminal LRR domain. There are two prominent members in the NLR family: nucleotide
binding oligomerization domain (NOD)1 and NOD2. NOD1 recognizes γ-D-glutamylmeso-diaminopimelic acid (iE-DAP, found in the peptidoglycan of gram-negative
bacteria), and NOD2 recognizes MurNAc-L-Ala-D-isoGln (MDP, found in all bacteria) in
the cytoplasm (Takeuchi & Akira, 2010). It has been shown that activated NOD1 and
NOD2 intermediate inflammation in the adipocytes and adipose tissue of high-fat dietinduced obese mice and obese humans (Zhao et al., 2011; Zhou, Zhou, Li, & Song,
2012). NOD1 and NOD2 mRNA expression is positively correlated with the
differentiation rate of primary adipocytes isolated from the subcutaneous abdominal
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WAT of obese women. Primary human adipocytes treated with NOD1 ligand (iE-DAP,
100 μg/mL) induce NF-κB expression as well as IL-6, IL-8, and MCP-1 production, but
no change is observed in primary human adipocytes treated with MDP (10 μg/mL)
(Zhou et al., 2012).
Similar to TLRs, NLRs are also responsible for inflammatory reactions through
the activation of MAPK and NF-κB pathways, leading to the production of
proinflammatory cytokines. Studies have shown that mRNA expression of NOD1 and
NOD2 is significantly increased in mature murine adipocytes, and NOD1, but not NOD2,
is highly expressed in epididymal and subcutaneous adipose tissue of high-fat diet (60%
fat for 20 weeks)-induced obese mice (C57BL/6J) (Zhao et al., 2011). MCP-1, CCL5,
TNF-α, and IL-6 expression through the MAPK/NF-κB pathway is significantly increased
in NOD1 ligand Tri-DAP (10-50 μg/mL for 15 hours)-induced 3T3-L1 adipocytes (Zhao
et al., 2011). NOD1/2 double knockout male mice (C57BL/6 strain) fed a high-fat diet for
16 weeks have less adipose tissue, decreased liver weight, and reduced blood glucose
level in insulin-tolerance compared to wild-type male C57BL/6 mice. NOD1 activation by
NOD1 ligand FK156 (100 μg) induces insulin intolerance in NOD1 knockout mice, which
is revealed by no change in blood glucose level. However, the glucose level is
increased in wild-type and NOD2 knockout mice (Schertzer et al., 2011). On the other
hand, NOD2 activation by NOD2 ligand MDP (5-10 μg/mL) significantly decreases 2deoxyglucose uptake in L6-GLUT4 muscle cells. Phosphorylation of MAPK and IRS-1
are increased in L6-GLUT4 muscle cells treated with 10 μg/mL of MDP (Tamrakar et al.,
2010).
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Inflammation in adipose tissue, a hallmark of obesity, interferes with insulin
resistance in WAT and energy expenditure in BAT, potentially leading to adipose tissue
dysfunction. Inflammation also inhibits white and brown adipocyte differentiation, which
disrupts energy storage in WAT and reduces BAT activation. Therefore, better
understanding of the adipose tissue inflammation mechanism can help in the prevention
of adipose dysfunction.

1.3 Novel targets for obesity treatment and prevention: Brown and
beige adipocytes
1.3.1 Browning and beige
The main cells in both types of adipose tissue are called adipocytes (Rosenwald
& Wolfrum, 2014). Interscapular BAT contains classic brown adipocytes, whereas
epididymal and subcutaneous adipose tissues contain classic white adipocytes
(Sanchez-Gurmaches & Guertin, 2014). White adipocytes have a single lipid droplet
consisting of triglycerides and a small number of mitochondria. In contrast, brown
adipocytes have multiple small lipid droplets and enriched amounts of mitochondria that
are closer to those of skeletal muscle cells rather than white adipocytes (Algire,
Medrikova, & Herzig, 2013; Giralt & Villarroya, 2013; Nakagami, 2013; A. Park, Kim, &
Bae, 2014; Rosenwald & Wolfrum, 2014). Besides white and brown adipocytes, a third
type has recently been discovered called beige adipocytes (Beranger et al., 2013; Giralt
& Villarroya, 2013), which is identified in WAT. They differ in that they have few
mitochondria and lower UCP-1 expression without stimuli. However, upon activation by
exposure to physiological, pharmacological, or hormonal stimuli, the cells demonstrate
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BAT-like phenotype with increased number of mitochondria, UCP-1 expression, and
cellular respiration, a process referred to as the “browning” of WAT (Barneda, Frontini,
Cinti, & Christian, 2013; Bartelt & Heeren, 2014; Bi & Li, 2013; Bonet, Oliver, & Palou,
2013; Elsen, Raschke, & Eckel, 2014; Giralt & Villarroya, 2013). Although certain cells
in WAT show the BAT phenotype, the cells are not exactly the same as the classic
brown fat cells, which is why the brown-like cells located in WAT have been called
“beige” or “brite (brown in white)” cells (Harms & Seale, 2013; Keipert & Jastroch, 2014;
P. Lee, Werner, Kebebew, & Celi, 2014; McMillan & White, 2015; A. Park et al., 2014; J.
Wu et al., 2012; J. Wu, Cohen, & Spiegelman, 2013).
Human beige cells have been detected in PET/CT scan images in the neck and
chest upon cold exposure (Bartelt & Heeren, 2014; J. W. Park et al., 2015). The number
of white adipocytes in WAT is decreased while BAT is increased when adult female
Sv129 mice are exposed to cold temperature for 10 days (Cinti, 2009). Obese patients
have fewer beige cells compared to lean patients (Fernández-Galilea et al., 2015; P.
Lee et al., 2014; Vijgen et al., 2011). Beige cells have also been detected in the WAT
deposits of lean rodents but not in obese rodents (Rachid et al., 2015; J. Wu et al.,
2012). Carey and colleagues have detected UCP-1 expression in differentiated primary
white adipocytes isolated from the abdominal subcutaneous adipose tissue of healthy
young adults but not in that of obese young adults (Carey et al., 2014). Expression of
genes representing general adipogenesis, browning, and beige adipogenesis is higher
in differentiated primary adipocytes than precursor cells (Carey et al., 2014). Although
genes for classic brown adipogenesis have not been sufficiently detected, precursor
cells in WAT have the potential to become brown-like adipocytes or beige adipocytes
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since genes related to browning and beige adipogenesis are highly expressed in the
primary adipocytes of WAT.
After beige cells are discovered, transdifferentiation, which is the transformation
of white cells into brown-like cells, has been used for research on preventing obesity.
Although white fat cells and brown fat cells have different characteristics, functions, and
morphology, they share pluripotent mesenchymal stem cell as a common precursor.
Hence, pluripotent mesenchymal stem cells are widely used for the browning process in
in vitro studies (Algire et al., 2013; Birerdinc, Jarrar, Stotish, Randhawa, & Baranova,
2013; Giralt & Villarroya, 2013; Nakagami, 2013; A. Park et al., 2014; Rosenwald &
Wolfrum, 2014). The regulators of the browning process are discussed in more detail in
a later section.
1.3.2 Origins of brown and beige adipocytes
The difference of preadipocytes among brown adipocytes, white adipocytes, and
beige adipocytes is the expression of myogenic regulatory factor (Myf)5, which is
essential for skeletal muscle function (Ott, Bober, Lyons, Arnold, & Buckingham, 1991).
Reduced muscle mass and delayed skeletal muscle regeneration are observed in Myf5
knockout mice (129Sv/C57BL/6 background) compared to wild-type mice (Ustanina,
Carvajal, Rigby, & Braun, 2007). BAT contains 95% Myf5-positive and 5% Myf5negative preadipocytes, while subcutaneous WAT contains 49% Myf5-positive and 51%
Myf5-negative cells, and visceral WAT contains 70% Myf5-positive and 30% Myf5negative preadipocytes (Sanchez-Gurmaches & Guertin, 2014). Brown adipocytes
derived are exclusively from Myf5-positive myogenic lineages that can also be muscle
cells, while white adipocytes are derived from Myf5-negative adipogenic lineages
21

(Sanchez-Gurmaches & Guertin, 2014). Beige adipocytes, however, have not been
clearly defined. Reviewers have suggested that beige adipocytes can be derived from
both Myf5-positive and -negative lineages, which exist in BAT and WAT, respectively
(Gilsanz, Hu, & Kajimura, 2012; Giralt & Villarroya, 2013). Hence, the Myf5 expression
of beige adipocytes is still questionable. In addition, the origin of beige adipocytes is
reversible in that beige adipocytes are derived from either white adipocyte precursor
cells or are converted from mature white adipocytes (Cinti, 2009; Q. A. Wang, Tao,
Gupta, & Scherer, 2013; J. Wu et al., 2012).
There are several phases in between pluripotent mesenchymal stem cells and
mature adipocytes, including the commitment and differentiation phases (Rosen &
MacDougald, 2006). Key regulators covert the pluripotent mesenchymal stem cells to
undifferentiated pre-cells such as osteoblasts, preadipocytes, and myoblasts (DiMarino,
Caplan, & Bonfield, 2013). When stem cells complete the commitment phase, the precells are differentiated by the regulation of specific transcriptional factors and become
bone cells, fat cells, or muscle cells with their specific properties (Alonso, Claros,
Becerra, & Andrades, 2008; Andrades et al., 2011; DiMarino et al., 2013).
1.3.3 Regulation of BAT development and function
Adipogenesis is a multi-step process, that includes growth arrest, clonal
expansion, and differentiation from preadipocytes to become mature adipocytes
(Carobbio, Rosen, & Vidal-Puig, 2013). Murine 3T3-L1 and 3T3-F442A white
preadipocytes are widely used in white adipogenesis studies, and immortalized brown
fat cell lines are available for brown adipogenesis studies (Moreno-Navarrete &
Fernández-Real, 2012). Furthermore, transgenic mice models are used for studies
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regarding adipose tissue function and development. A review paper (Harms & Seale,
2013) published in 2013 indicates enhanced beige fat activity in five types of transgenic
mouse models with overexpression of prostaglandin-endoperoxide synthase (PTGS)2,
forkhead box protein c (Foxc)2, PR domain containing (PRDM)16, phosphatase and
tensin homolog (Pten), and UCP-1. Several transcriptional factors have been identified
as regulating adipogenesis and adipose tissue development (Siersbæ k, Nielsen, &
Mandrup, 2012). Many studies on WAT and white adipocytes have already been
conducted for the prevention of obesity, from benchside to human studies (Cummins et
al., 2014; E. Y. Kim et al., 2015; Vázquez-Vela, Torres, & Tovar, 2008). Over the past
decade, however, there has been increasing interest in the function and development of
BAT and brown adipocytes for obesity prevention (Beranger et al., 2013; Bi & Li, 2013;
Elattar & Satyanarayana, 2015; Harms & Seale, 2013; Lo & Sun, 2013; Saely et al.,
2012; Seale, Kajimura, & Spiegelman, 2009; Virtanen et al., 2013; Vosselman et al.,
2013; Whittle, Relat-Pardo, & Vidal-Puig, 2013). Therefore, in this section discusses
three key regulators for BAT function and development: UCP-1, PGC1α, and PPARγ.
UCP-1 is a key brown marker gene for adaptive non-shivering thermogenesis in
BAT (Cypess et al., 2009; Kozak, Koza, & Anunciado-Koza, 2010; Richard & Picard,
2011). UCP-1 is located in the inner mitochondrial membrane and produces heat in the
ETC (Symonds, 2013). The expression of UCP-1 is regulated by several factors,
including chronic cold exposure (van der Lans et al., 2013), activated hormone
receptors (Martinez de Mena, Scanlan, & Obregon, 2010), the activation of the SNS
(Mottillo et al., 2014), and other transcriptional factors (Symonds, 2013). Mice exposed
to cold temperature have a greater UCP-1 expression in BAT than mice exposed to
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warm temperature (Dong et al., 2013). UCP-1 knockout mice (C57BL/6J strain) have
more cold-sensitive characteristics and a lesser ability to produce heat than wild-type
mice (C57BL/6J) (Stier et al., 2014). The UCP-1 mRNA level is much lower in leptindeficient obese mice than in wild-type mice (Ricciardi et al., 2014), and UCP-1 knockout
mice are more likely to become obese when fed a high fat diet (Feldmann,
Golozoubova, Cannon, & Nedergaard, 2009). In addition, UCP-1 is also regulated by
the activation of cAMP, the thyroid hormone, and PPAR response elements (Martinez
de Mena et al., 2010; Sears, MacGinnitie, Kovacs, & Graves, 1996). Mice with a
reduced triiodothyronine (T3) level have lesser UCP-1 expression and lesser
thermogenic resistance when exposed to cold temperature (Marrif et al., 2005).
Moreover, the activation of the β-adrenergic receptor also induces UCP-1 expression
(Mattsson et al., 2011). The activation of the β-adrenergic receptor activates cAMP and
PKA activation and then activates downstream pathways, such as p38 MAPK,
increasing UCP-1 expression (Cao, Medvedev, Daniel, & Collins, 2001; Chernogubova,
Cannon, & Bengtsson, 2004; Collins, 2011; Hutchinson, Chernogubova, Dallner,
Cannon, & Bengtsson, 2005). Therefore, UCP-1 is essential for BAT function in
thermogenesis in a cold environment.
Peroxisome proliferator-activated receptor (PPAR) coactivator 1α (PGC1α), a
transcriptional factor, is well known as a coactivator of PPAR (Medina-Gomez, Gray, &
Vidal-Puig, 2007). PGC1α plays a critical role in tissue-specific sites that have a high
number of mitochondria (Huss & Kelly, 2005). PGC1α induces hepatic gluconeogenesis
against fasting, leading to the maintenance of blood glucose homeostasis in the liver
(Rodgers et al., 2005; Y. Wang et al., 2012). PGC1α also regulates glucose uptake and
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energy metabolism upon physical activities in the skeletal muscle (Baar et al., 2002;
Bonen, 2009; Ehrenborg & Krook, 2009; C. Kang & Li Ji, 2012; Y.-X. Wang, 2010).
Furthermore, it plays a more important role in mitochondria biogenesis in BAT than
WAT, and it is responsible for the UCP-1 expression leading to heat production
(Bostrom et al., 2012; H. Y. Chen, Liu, Salter, & Lomax, 2013). Therefore, like UCP-1,
PGC1α is also significantly induced in cold temperatures and by β-adrenergic
stimulation (Jan Nedergaard, Bengtsson, & Cannon, 2007). PCG1α expression is
increased by the activation of cAMP-PKA signaling upon β-adrenergic stimulation (Cao
et al., 2004; Singh, Simpson, & Bennett, 2015). Previous animal studies have shown
that PGC1α knockout mice have significantly reduced thermogenic function with the
exhibition of cold intolerance in response to cold exposure (Lin et al., 2004). In addition,
PGC1α plays a major role in mitochondria biogenesis and the oxidative pathway in BAT
with PPARγ and PPARα (Hondares et al., 2011). Overexpression of PGC1α in BAT
increases the number of mitochondria and thermogenic-associated genes, including
UCP-1 (Bostrom et al., 2012; Valle, Á lvarez-Barrientos, Arza, Lamas, & Monsalve,
2005). Therefore, PGC1α is essential for BAT development and UCP-1 expression.
PPARγ plays a critical role in regulating adipogenesis in adipose tissue, as well
as in adipocytes (Chawla, Schwarz, Dimaculangan, & Lazar, 1994; Lowell et al., 1999;
Spiegelman, 1998). Studies have shown that PPARγ is required for BAT development
(S. Kajimura, Seale, & Spiegelman, 2010; J. Nedergaard, Petrovic, Lindgren,
Jacobsson, & Cannon, 2005; N. Petrovic et al., 2010), and PPARγ knockout mice
reduce BAT development and thermogenic function (Jones et al., 2005). The activation
of PPARγ induced by ligands promotes adipose tissue function and increases
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adipocytes, leading to the increased expression of lipogenic genes such as fatty acid
binding protein 4 (FABP4) (Benvenuti et al., 2007; Mallon et al., 2008; Tzeng, Chang, &
Liu, 2014). Knocking out the PPARγ gene in the adipose tissue of mice leads to loss of
fat and degeneration of adipose tissue function (Jones et al., 2005; F. Wang, Mullican,
DiSpirito, Peed, & Lazar, 2013). In vitro, PPARγ is a master regulator of adipocyte
differentiation from preadipocytes to mature adipocytes, and it increases the adipogenic
gene expression (Chawla et al., 1994; J. Nedergaard et al., 2005; Spiegelman, 1998).
Likewise, UCP-1 expression is regulated by PPARγ activation in brown adipocytes. It
has been shown that rosiglitazone, a PPARγ agonist, induces UCP-1 expression in
brown adipocytes (Pardo et al., 2011; Natasa Petrovic et al., 2010; Teruel, Hernandez,
Benito, & Lorenzo, 2003).
1.3.4 Regulation of the browning process
As discussed in a previous section, browning is the process of transdifferentiation
from white adipocytes to brown-like adipocytes or beige adipocytes (Beranger et al.,
2013; Bi & Li, 2013; Cinti, 2009). In vivo, browning of WAT is when WAT takes BAT
phenotype upon certain stimuli (Barneda et al., 2013; Bi & Li, 2013; Lo & Sun, 2013),
such as exposure to cold, PPARγ agonist, or β-adrenergic receptor activator, which lead
to thermogenesis, adipogenesis, and/or mitochondria biogenesis (Mineo et al., 2012;
Nguyen et al., 2011; Teulier et al., 2010; van der Lans et al., 2013; van Marken
Lichtenbelt & Schrauwen, 2011). Therefore, brown-specific markers and regulators- i.e.
UCP-1, PGC1α, PPARγ and several newly discovered regulators- are key regulators for
the browning process (Lo & Sun, 2013).

26

PRDM16 is major factor for brown adipogenesis in WAT and it works with other
regulators for BAT development, including UCP-1, PGC1α, and PPARγ (Bartelt &
Heeren, 2014; Lo & Sun, 2013; Seale et al., 2008). PRDM16 is essential for conversion
from pluripotent mesenchymal stem cells to brown-like cells (Algire et al., 2013;
Beranger et al., 2013; J. Wu et al., 2012). It has been shown that PRDM16 has higher
expression in primary adipocytes isolated from subcutaneous WAT but not visceral
WAT. UCP-1 expression is also enriched in primary adipocytes. Primary subcutaneous
adipocytes isolated from PRDM16 knockout C57BL/6 mice significantly reduce total and
uncoupled respiration compared to wild-type mice (Cohen et al., 2014). The role of
PRDM16 for browning has also been determined in some animal studies. PRDM16,
UCP-1, and PGC1α mRNA expression in subcutaneous WAT is reduced in PRDM16
knockout C57BL/6 mice fed a high-fat diet when the mice are exposed to cold
temperature (Cohen et al., 2014). In contrast, PRDM16 transgenic mice (C57BL/6
strain) have greater energy expenditure and increased brown adipose-specific markers,
UCP-1 and PGC1α mRNA levels in WAT. PRDM16 transgenic mice show reduced body
weight and blood glucose in response to a high-fat diet (Ohno, Shinoda, Spiegelman, &
Kajimura, 2012; Seale et al., 2011).
Bone morphogenetic proteins (BMPs), transforming growth factor beta (TGF-β)
family, are multi-functional growth factors and are initially discovered to induce bone
formation. A comprehensive analysis study has shown that five BMPs are commonly
used for both osteogenic and adipogenic differentiation. It has been confirmed that
BMP2,4,6,7, and 9 induce osteogenic differentiation and adipogenic differentiation,

27

which is revealed by alkaline phosphatase activity at day 7 and oil red O staining at day
20, respectively, in C3H10T1/2 mesenchymal stem cell (Q. Kang et al., 2008).
BMP2, BMP4, and BMP7 are mainly used and involved in adipogenic
differentiation. BMP2 and BMP4 are responsible for conversion of mesenchymal stem
cells to white adipocytes, whereas BMP7 is responsible for brown adipogenesis (Tseng
et al., 2008). Recently, it has been discovered that BMP is an essential factor for
commitment of mesenchymal stem cells to adipocyte lineage (H. Huang et al., 2009).
During the commitment phase, mesenchymal stem cells treated with 10 ng/mL of BMP2
and 4, followed by induction of differentiation media resulted in increased lipid
accumulation, which is assessed by oil red O staining (H. Huang et al., 2009). BMP7
(3.3 nM for 8 days) induces differentiation of primary brown preadipocytes derived from
newborn wild-type mice to adipocytes, but 3T3-L1 preadipocytes are not differentiated
into adipocytes by BMP7 (Tseng et al., 2008). In addition, gene expression of PPARγ,
C/EBPα, FABP4, PGC1α, PRDM16, nuclear respiratory factor (NRF)-1, and
transcription factor A (TFAM) are significantly increased in BMP7-treated brown
adipocytes (Tseng et al., 2008). BMP7 treatment in the commitment phase also induces
UCP-1 expression in C3H10T1/2 cells (Tseng et al., 2008). In contrast, Xue has shown
that C3H10T1/2 cells treated with either BMP4 (20 ng/mL) or 7 (100 ng/mL) during the
commitment phase significantly induce lipid accumulation and increase brown fat
specific markers, including UCP-1 and PGC1α expression, as well as mitochondrial
components (Xue et al., 2014). The same results have been shown in 3T3-L1
adipocytes (Xue et al., 2014).
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BMP signaling also plays an important role in browning of WAT. Recently, it has
been shown that BMP4 also promotes a white-to-brown transition in primary human
adipose stem cells with the induction of BAT-specific markers, including UCP-1 and
BAT development regulators, such as PRDM16 (Elsen, Raschke, Tennagels, et al.,
2014; Gustafson et al., 2015). UCP-1, PGC1α, and PRDM16 are increased in BMP4treated 3T3-L1 adipocytes (Qian et al., 2013). A large number of multilocular brown
adipocytes and a small number of unilocular white adipocytes are found in BALB/C
nude mice injected with stem cells treated with either BMP4 or 7 (Xue et al., 2014).
BMP is also responsible for thermogenesis to maintain body temperature. It has
confirmed that newborn BMP receptor (BmprIB) knockout mice (C57BL/6J strain) take
more time to return to normal temperature after cold exposure compared to wild-type
newborn mice (11 days vs. 48 hours) (Schulz et al., 2013).
Irisin, first reported in 2012, is well known as the ‘exercise hormone’, because it
is produced during exercise and leads to energy expenditure in both mice and humans
(Bostrom et al., 2012). Also called myokine, irisin was initially discovered in muscle cells
after exercise. Irisin production from primary human skeletal muscle cells is significantly
different between healthy adults and diabetic adults, but not obese adults [220]. The
concentration of irisin is in the same range of that of insulin and leptin in human blood
(Jedrychowski et al., 2015). Serum irisin levels are higher in exercised B6 mice (12
weeks) and non-diabetic obese male adults aged 50 days (free wheel running for 3
weeks and endurance exercise for 10 weeks, respectively). Another study, however,
has shown that plasma irisin levels after 26 weeks of training are not significantly
different between sedentary, aerobic endurance training, and strength endurance
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training groups among healthy humans (age 50s, females and males, not obese and
diabetic) (Hecksteden et al., 2013). These differences may be due to the different
samples sizes, health conditions (healthy vs. obese vs. diabetic), age (20s vs. 50s), and
gender (male only vs. male/female mix) used in different studies.
Recently, plasma irisin is detected by mass spectrometry in young healthy
subjects. A high-intensity aerobic training group at over 70% aerobic capacity (3
days/week cycle ergometer and 2 days/week walking on a treadmill for 12 weeks) has
more plasma irisin than a sedentary group (Jedrychowski et al., 2015). Purified r-irisin
(0.5 μg/g/d for 14 days using intraperitoneal injection) increases UCP-1 and PGC1α
gene expression and UCP-1-positive adipocytes in subcutaneous WAT of C57BL/6
mice fed a high-fat diet (60% fat) (Zhang et al., 2014). After 14 days, the body weight is
decreased in irisin-injected mice compared to saline-injected mice fed a high-fat diet
(Zhang et al., 2014). In addition, it has been shown that irisin increases UCP-1 and the
thermogenic-related gene expression in the 3T3-L1 mature adipocytes (C. Wang et al.,
2015) and WAT of mice (Bostrom et al., 2012). Irisin could be a potential target to
prevent obesity through the browning of WAT. More studies are still needed to
determine the underlying mechanism of the browning effect of irisin.
1.3.5 Nutritional intervention of BAT development and browning
It has been shown that both BAT and the browning of WAT are responsible for
energy expenditure in many ways, including thermogenesis, mitochondria biogenesis,
and fatty acid oxidation (Bartelt & Heeren, 2014; Cereijo et al., 2015; Cohen &
Spiegelman, 2015; P. Lee & Greenfield, 2015; Lidell, Betz, & Enerback, 2014; McMillan
& White, 2015; Roman et al., 2015; Symonds, 2013; Virtanen et al., 2013; Vosselman et
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al., 2013; Zafrir, 2013). Thus, several nutritional compounds have been experimentally
established to increase BAT function and energy expenditure to prevent obesity (Bonet
et al., 2013; S. Wang et al., 2014).
Resveratrol is a type of natural polyphenolic compound found widely in the skins
of grapes, red wine, and berries, and is well known as a protective agent against
metabolic diseases (Lagouge et al., 2006). Numerous animal studies have supported
the beneficial effects of resveratrol on obesity. Resveratrol reduces body weight and
insulin resistance in high-fat diet-fed obese mice (C57BL6J) in the short term (400
mg/kg/day in commercial high fat diet purchased from Research diet for 15 weeks), as
well as in the long term (25 mg/kg/day in 54.35% fat diet for 20 months) (Lagouge et al.,
2006; Montero, de la Fuente, Fonteriz, Moreno, & Alvarez, 2014). Recently, resveratrol
has been shown to promote cAMP-AMPK-PGC1α signaling, leading to the upregulating
of mitochondria biogenesis and function (S. Wang et al., 2015). Lipid accumulation is
significantly decreased in stromal vascular cells, isolated from inguinal WAT that are
treated with 20 μM resveratrol.
Differentiated stromal vascular cells treated with 10 μM resveratrol significantly
increase BAT-specific genes, UCP-1, PGC1α, and PRDM16; beige adipocyte selective
genes, CD137 and transmembrane protein (TMEM)26; and AMPK phosphorylation (S.
Wang et al., 2015). An animal study has supported that feeding a high-fat diet (45% fat)
containing 0.1% resveratrol to CD1 female mice results in reduced body weight,
increased AMPK phosphorylation, and increased UCP-1 and PRDM16 expression, but
not PPARγ expression, in contrast to control mice fed a high-fat diet only (S. Wang et
al., 2015). The thermogenic gene and the BAT-specific marker, the UCP-1 gene, is also
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upregulated in BAT of male mice fed a resveratrol containing diet (4g/kg) (Andrade et
al., 2014). Resveratrol also has novel browning properties in cell models and affects the
number of mitochondria and fatty acid oxidation and UCP-1 expression in 3T3-L1
adipocytes (Mercader, Palou, & Bonet, 2011; Rayalam, Yang, Ambati, Della‐Fera, &
Baile, 2008). Resveratrol (20 μM) increases palmitate oxidation in both primary mouse
embryonic fibroblast-derived adipocytes and 3T3-L1 adipocytes. In addition, resveratrol
significantly increases UCP-1 expression in primary mouse embryonic fibroblast-derived
adipocytes, but not in 3T3-L1 adipocytes (Mercader et al., 2011). Another study,
however, has shown that resveratrol (25 μM) significantly decreases lipid accumulation
and increases UCP-1 expression in 3T3-L1 adipocytes (Rayalam et al., 2008).
Polyunsaturated fatty acid (PUFA) contains two or more double bonds and
includes the essential fatty acids, α-linolenic acid (ω-3) and linoleic acid (ω-6), which are
known as anti-oxidant reagents (Buckley & Howe, 2010). Linoleic acid has provided
browning effects in animal models. A diet containing linoleic acid (20% linoleic acid
applied in 6.5% total lipid) increases UCP-1 and PGC1α gene expression in the
epididymal WAT of leptin-deficient ob/ob mice (Wendel, Purushotham, Liu, & Belury,
2009). In addition, the omega-3 PUFA, eicosapentaenoic acid (EPA, 20:5) and
docosahexaenoic acid (DHA, 22:6) found in fish oil, diminish obesity in animals (Buckley
& Howe, 2010). Wistar rats fed a standard diet supplemented with either EPA or DHA
show significantly decreased body weight gain (-27.4 and -22.1%, respectively)
compared to standard diet only (10.8%). In addition, high-fat diet supplemented with
either EPA or DHA also reduces body weight gain (8.8 and 5.5%, respectively)
compared to a high-fat diet alone (15.3%) in wistar rats (Poudyal, Panchal, Ward, &
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Brown, 2013). Omega-3 PUFA-supplemented high-fat diet (44% of lipids are replaced
by EPA and DHA) increases fatty acid oxidation and mitochondria biogenesis by
increasing the PGC1α and NRF-1 gene expressions in the epididymal WAT of male
C57BL/6J mice (Flachs et al., 2005). Moreover, EPA and DHA enhance BAT weight
with higher mitochondrial protein in high-fat diet-fed male wistar rats (Oudart et al.,
1997).
Capsaicin has also been studied in regard to its role in BAT function and
browning effects (Yoneshiro, Aita, Kawai, Iwanaga, & Saito, 2012). Capsaicin can be
found in peppers and spicy food ingredients (Hayman & Kam, 2008). Capsaicin has
been confirmed as an anti-obesity reagent targeting WAT and weight control in
numerous previous studies, from in vitro to clinical human studies (Hwang et al., 2005;
Joo, Kim, Choi, & Yun, 2010; J.-H. Kang et al., 2011; J. H. Kang et al., 2010; M. S. Lee,
Kim, Kim, & Kim, 2011; Lejeune, Kovacs, & Westerterp-Plantenga, 2003). Recently,
several studies have shown that capsaicin promotes BAT thermogenesis and energy
expenditure in animal and human studies (Okamatsu-Ogura et al., 2015; Saito &
Yoneshiro, 2013; Yoneshiro et al., 2012). Capsaicin administration (0.3% w/w for 8
weeks) together with exercise (free access to a running wheel) significantly increases
BAT functions and lipolysis through cAMP-PKA pathways in high-fat diet-induced obese
C57BL/6J mice (Ohyama et al., 2015). In addition, capsaicin (2 mg/kg BW dissolved in
0.9% saline for 12 weeks) upregulates brown adipocyte-specific markers, including
UCP-1, PGC1α, and cell death-inducing DNA fragmentation factor alpha-like effector A
(CIDEA) in subcutaneous WAT of regular chow-fed LACA mice (Baboota et al., 2014).
A low dose of capsaicin at 1μM inhibits lipid accumulation and induces browning
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through enhanced beige adipocytes and brown adipocyte-specific markers in 3T3-L1
adipocytes. In contrast, high dose of capsaicin at 100 μM increases lipid accumulation
and decreases brown adipocytes-specific markers (Baboota et al., 2014).
Ginsenoid Rb1 is a major component found in ginseng (Leung & Wong, 2010). A
previous study has shown that ginsenoid Rb1 significantly enhances glucose tolerance
and increases insulin sensitivity via AMPK activation in male rats (Shen et al., 2015).
Very recently, it has been found that ginsenoid Rb1 (10 μM) promotes browning effects
through the amplified expression of UCP-1, PGC1α, and PRDM16, increased
mitochondria respiration measured by oxygen consumption rate (OCR), and PPARγ
activation in 3T3-L1 adipocytes (Mu et al., 2015).
In summary, various studies have shown evidence that BAT has properties
related to energy expenditure while WAT is responsible for energy storage. Although
BAT is detected in human adults, the amount of BAT is very low compared to infants.
Instead, WAT increases with age, and human adults have plenty. Thus, the
development of BAT as well as brown-like cells in WAT could have beneficial effects for
the prevention of obesity. Understanding the mechanism of BAT function and the
browning of WAT would be advantageous. The specific aims of this dissertation are to
investigate whether 1) activation of PRRs induces inflammation and reduces UCP-1 and
mitochondrial respiration in classic brown adipocytes; 2) activation of PRRs suppresses
brown-like adipogenesis in C3H10T1/2 mesenchymal stem cells and brown
preadipocytes; and 3) whether nutritional compound boosts brown adipocytes
phenotypes in β-AR activation-induced 3T3-L1 white adipocytes.
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CHAPTER II
ACTIVATION OF PATTERN RECOGNITION RECEPTORS IN BROWN
ADIPOCYTES INDUCES INFLAMMATION AND SUPPRESSES
UNCOUPLING PROTEIN 1 EXPRESSION AND MITOCHONDRIAL
RESPIRATION
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2.1 Abstract
Pattern recognition receptors (PRR), Toll-like receptors (TLR), and nucleotideoligomerization domain-containing proteins (NOD) play critical roles in mediating
inflammation and modulating functions in white adipocytes in obesity. However, the role
of PRR activation in brown adipocytes, which are recently found to be present in adult
humans, has not been studied. Here, we report that mRNA of TLR4, TLR2, NOD1, and
NOD2 is upregulated, paralleled with upregulated mRNA of inflammatory cytokines and
chemokines in the brown adipose tissue (BAT) of the obese mice. During brown
adipocyte differentiation, mRNA and protein expression of NOD1 and TLR4, but not
TLR2 and NOD2, is also increased. Activation of TLR4, TLR2, or NOD1 in brown
adipocytes induces activation of NF-κB and MAPK signaling pathways, leading to
inflammatory cytokine/chemokine mRNA expression and/or protein secretion. Moreover,
activation of TLR4, TLR2, or NOD1 attenuates both basal and isoproterenol-induced
uncoupling protein 1 (UCP-1) expression without affecting mitochondrial biogenesis and
lipid accumulation in brown adipocytes. Cellular bioenergetics measurements confirm
that attenuation of UCP-1 expression by PRR activation is accompanied by suppression
of both basal and isoproterenol-stimulated oxygen consumption rates and isoproterenolinduced uncoupled respiration from proton leak; however, maximal respiration and ATPcoupled respiration are not changed. Further, the attenuation of UCP-1 by PRR
activation appears to be mediated through downregulation of the UCP-1 promoter
activities. Taken together, our results demonstrate the role of selected PRR activation in
inducing inflammation and downregulation of UCP-1 expression and mitochondrial
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respiration in brown adipocytes. Our results uncover novel targets in BAT for obesity
treatment and prevention.
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2.2 Introduction
Brown adipose tissue (BAT) is a specialized tissue whose function is to produce
heat through nonshivering thermogenesis. BAT is found in relative abundance in small
eutherian mammals, such as rat or mice, to allow the animals to live in a cold
environment without utilizing shivering mechanism to produce heat (Cannon &
Nedergaard, 2004). The thermogenic property of BAT is conferred to mainly by the
functions of uncoupling protein 1 (UCP-1), which is uniquely expressed and localized in
the inner membrane of brown adipocyte mitochondria to uncouple ATP synthesis from
respiration (Nicholls & Locke, 1984; Ricquier, 2005). BAT is heavily innervated by
sympathetic efferent fibers, and the release of norepinephrine by these fibers not only
increases BAT thermogenic activity (i.e., heat production) but also thermogenic capacity
(i.e., brown adipogenesis, mitochondrial biogenesis, and synthesis of UCP-1 and other
BAT thermogenic proteins) (Richard & Picard, 2011).
It was thought until recently that humans only possess BAT when they were
newborn infants and that BAT quickly regresses following birth. However, new evidence
from positron emission tomography/computed tomography scanning has revealed
symmetrical fat depots in the cervical, supreclavicular, and parasphinal regions in adult
humans that have all the characteristics of BAT (Cypess et al., 2009; Saito et al., 2009;
van Marken Lichtenbelt et al., 2009; Virtanen et al., 2009; Zingaretti et al., 2009).
Recent gene expression profilings have confirmed many classical BAT features in the
supraclavicular regions of adult humans (Cypess et al., 2013; Jespersen et al., 2013).
Due to its energy-dissipating activity, BAT has become a novel target for obesity
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treatment and prevention (Vijgen & van Marken Lichtenbelt, 2013; Vosselman, van
Marken Lichtenbelt, & Schrauwen, 2013).
In contrast to white adipose tissue (WAT), whose function is to store energy,
brown adipocytes are multilocular with many small lipid droplets and contain a large
number of mitochondria, compared with a single large lipid droplet and few mitochondria
in white adipocytes. It is now recognized that obesity is associated with chronic
inflammation in WAT at both local and systemic levels. Adipose inflammation,
characterized by elevated pro inflammatory cytokine/chemokine expression and
secretions and infiltration of immune cells, including macrophages, is thought to
contribute to obesity associated comorbidities, such as insulin resistance and diabetes
(Gregor & Hotamisligil, 2011; Kwon & Pessin, 2013; Ouchi, Parker, Lugus, & Walsh,
2011; Rasouli & Kern, 2008).
The mechanisms underlying adipose inflammation in obesity have been the
focus of intense research (Sun, Ji, Kersten, & Qi, 2012). Recent studies suggest that
adipose inflammation is mediated through the activation of germline-encoded pattern
recognition receptors (PRR) in the adipose tissue/adipocytes (Jin, Henao-Mejia, &
Flavell, 2013). PRRs belong to innate immune system and are responsible for the
sensing of invading microbial pathogens and activate specific signaling pathways
leading to distinct inflammatory and immune responses in the host cells (Akira,
Uematsu, & Takeuchi, 2006; Kawai & Akira, 2009). Toll-like receptors (TLR) and Nodlike receptors (NLR) are two prominent families of PRRs. TLRs are transmembrane
receptors composed of extracellular leucine-rich repeat (LRR) motifs and a cytoplasmic
Toll/interleukin-1 receptor (TIR) homology domain. So far, 10 and 12 functional TLRs
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have been identified in humans and mice, respectively. The respective bacterial or viral
pathogen-associated molecular patterns (PAMP) that individual TLR detects have been
characterized (Akira et al., 2006). In contrast, NLRs are a family of cytosolic sensors
that play important roles in innate immunity and inflammation (Inohara, Chamaillard,
McDonald, & Nunez, 2005). These NLRs display a central nucleotide-binding domain,
an NH2-terminal protein interaction domain, and a COOH-terminal LRR domain. Two
prominent members of NLRs are NOD1 and NOD2, and each recognizes a distinct
minimal peptidoglycan structure: NOD1 recognizes a dipeptide, γ-D-Glu-mesodiaminopimelic acid (iE-DAP) (Chamaillard et al., 2003), or a tripeptide, L-Ala-γ-D-Glumeso-diaminopimelic acid (Tri-DAP) (Girardin, Boneca, Carneiro, et al., 2003) derived
mostly from Gram-negative bacteria; NOD2 recognizes the peptidoglycan muramyl
dipeptide MurNAc-L-Ala-D-isoGln (MDP) from both Gram-positive and Gram-negative
bacteria (Girardin, Boneca, Viala, et al., 2003; Inohara et al., 2003). Various PRRs,
including TLR4, TLR2, NOD1, and NOD2, have been detected in WAT and/or white
adipocytes, and activation of PRR induces a proinflammatory response (Davis,
Braucher, Walker-Daniels, & Spurlock, 2011; Song, Kim, Yoon, & Kim, 2006; Zhao, Hu,
Zhou, Purohit, & Hwang, 2011), resulting in adipocyte dysfunction and disturbed
homeostasis of whole body metabolism (Ehses et al., 2010; Himes & Smith, 2010;
Schertzer et al., 2011; Shi et al., 2006).
Here, we report the expression of NOD1, NOD2, TLR4, and TLR2 in classical
BAT of mouse models of obesity and during brown adipocyte differentiation. Activation
of NOD1, TLR4, and TLR2, but not NOD2, induces a proinflammatory response in
brown adipocytes through NF-κB and MAPK signaling pathways. Moreover, the
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activation of these selected PRRs leads to downregulation of basal and isoproterenolinduced UCP-1 mRNA and protein expression and suppresses mitochondrial respiration
in brown adipocytes.
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2.3 Materials and methods
Reagents
NOD1 synthetic ligand lauroyl-γ-D-Glu-meso-diaminopimelic acid (C12-iEDAP)
and TLR2 ligand a synthetic triacylated lipoprotein Pam3CSK4 were from Invivogen
(San Diego, CA). Ultra pure TLR4 ligand lipopolysaccharide (LPS) was from List
Biological Laboratories (Campbell, CA). 3-Isobutyl-L-methylxanthine, T3,
dexamethasone, insulin, indometacin, and isoproterenol were from Sigma (St. Louis,
MO). The pharmacological MAPK inhibitors PD98054, SP600125, and SB203580 were
from Tocris Bioscience (Ellisville, MI), and the NF-κB inhibitors QNZ and caffeic acid
phenethyl ester (CAPE) were from Cayman Chemical (Ann Arbor, MI). Antibodies antiphospho-ERK1/2(Thr202/Tyr204) (no. 4376), anti-ERK1/2 (no. 4695), anti-phosphop38(Thr180/Tyr182) (no. 9211), anti-p38 (no. 9212), anti-phospho-JNK(Thr183/Tyr185)
(no. 9251), anti-JNK (no. 9258), anti-phospho-p65(Ser536) (no. 3033), anti-p65 (no.
3034), anti-phospho-IκB(Ser32) (no. 2859), anti-proliferator-activated receptor-gamma
(PPARγ; no. 2443) were from Cell Signaling Technology (Danvers, MA). Anti-UCP-1
antibody (U6382) was from Sigma-Aldrich (St. Louis, MO). Anti-peroxisome proliferatoractivated receptor-gamma coactivator-1α (PGC-1α) antibody (AB3242) was from
Millipore (Temecula, CA). Antibodies anti-NOD1 (ab105338), anti-TLR4 (ab13867), and
anti-TLR2 (ab108998) were from Abcam (Cambridge, MA).
Animals
Diet-induced obesity (DIO) mice and ob/ob and their respective controls have
been described previously (Zhao et al., 2011). The mice were purchased from the
Jackson Laboratory (Bar Harbor, ME). For DIO study, male C57BL/6J mice (n=7 per
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group) were fed with a high-fat diet (60% Kcal% from fat; Research Diets) or regular
chow diet for 20 wk before being killed at 26 wk of age. Male ob/ob and their control
mice (n=6 per group) were fed with chow diet for 8 wk before being killed at 14 wk of
age. Upon death, interscapular BAT was removed and immediately snap frozen in liquid
nitrogen and stored at -80°C until analysis. The mice studies were approved by the
Institutional Animal Care and Use Committee at the University of Tennessee.
Brown fat cell culture and differentiation
The murine brown fat cell line was a generous gift from Dr. Johannes Klein
(University of Lubeck, Lubeck, Germany), who has generated the cell line from the
interscapular brown fat of 6- to 7-wk-old of C57BL mice (Klein, Fasshauer, Klein, Benito,
& Kahn, 2002). Brown fat cells were maintained in DMEM supplemented with 20% fetal
bovine serum (FBS; Atlas Biologicals, Fort Collins, CO) at 37°C humidified atmosphere
of 5% CO2 in air until they reached confluence [designated as day 0 (D0)]. The cells
were changed into differentiation media DMEM supplemented with 20% FBS, 1 nM T3,
and 20 nM insulin for 24 h, followed by induction in DMEM supplemented with 20%
FBS, 1 nM T3, 20 nM insulin, 0.125 mM indometacin, 5 μM dexamethasone, and 0.5
mM 3-isobutyl-L-methylxanthine for another 24 h. The cells were then changed back to
differentiation media and subsequently changed every 2 days until fully differentiated
into brown adipocytes on day 6 (D6).
PRR stimulation
Differentiated brown adipocytes were serum starved in DMEM containing 1%
FBS for 12–15 h and stimulated with vehicle control, C12-iEDAP, LPS, or Pam3CSK4
as indicated. Total RNA and media were collected for cytokine/chemokine mRNA
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expression and protein secretion analysis. For the studies using the inhibitors of NF-κB
or MAPK, cells were pretreated with the inhibitor for 1 h and were co-stimulated with the
respective ligand for the indicated time.
Western blot analysis
Total cell lysates were prepared and protein concentrations were determined by
the BCA assay kit (Thermo Scientific, Waltham, MA). Fifty micrograms of total cell
lysates were subjected to 10% SDS-PAGE and transferred to polyvinylidene difluoride
membrane (Bio-Rad, Hercules, CA). The membrane was blocked in 20 mM Tris·HCl,
137 mM NaCl, and 0.1% Tween 20 (pH 7.4) containing 5% nonfat milk. The membrane
was immunoblotted with primary antibodies at 4°C overnight followed by secondary
antibody conjugated with horseradish peroxidase (GE Healthcare). The signal was
quantified by densitometry using a ChemiDocXRS+ imaging system with ImageLab
software (Bio-Rad).
RNA preparation and quantitative real-time PCR analysis
Total RNA was prepared from BAT from DIO or ob/ob mice or from brown
adipocytes using TRI reagent (Molecular Research Center, Cincinnati, OH) according to
the manufacturer’s instructions. Total RNA abundance was quantified using NanoDrop
ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). Reverse
transcription was carried out using Fermentas first strand synthesis kit (Thermo
Scientific, Pittsburgh, PA) according to the manufacturer’s instructions. mRNA
expression of PRRs, brown adipocyte marker genes, inflammatory cytokine/chemokine
genes, and the housekeeping gene 36B4 was measured quantitatively using genespecific TaqMan gene expression assays (Applied Biosystems) (for samples of BAT) or
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Absolute Blue QPCR SYBR Green ROX mix (Thermo Fisher Scientific) and genespecific primers (for samples of brown adipocytes). Specific primer sequences can be
provided upon request. PCR reactions were run in a 96-well format using an ABI
7300HT instrument. Cycle conditions were 50°C 2 min, 95°C 15 min and then 40 cycles
of 95°C for 15 s/60°C for 1 min. Relative gene expression was calculated using the 2ΔΔCt

method, which normalizes against 36B4.

Reporter gene assays
For NF-κB-Luc experiments, brown adipocytes in 24-well plates were infected
with adenovirus encoding NF-κB-Luc reporter gene for 24 h. The cells were stimulated
with C12-iEDAP, LPS, Pam3CSK4, or the vehicle control for 15 h. For UCP-1-Luc
experiments, brown adipocytes were subcultured and transfected with a mouse 3.1 kb
UCP-1 promoter luciferase construct (UCP-1-Luc) (Rim & Kozak, 2002) and
subsequently pretreated with the ligand for each PRR or the vehicle control for 1 h and
then cotreated with isoproterenol for 15 h. The cell lysate was prepared and reporter
luciferase activities were measured with GloMax Luminometer (Promega, Madison, WI).
Relative luciferase activities were normalized by protein concentrations and expressed
as fold of vehicle control.
Measurement of cytokine/chemokine
The supernatant from brown adipocytes that were stimulated with PRRs was
collected and the levels of monocyte chemotactic protein 1 (MCP-1), interleukin 6 (IL-6),
and regulated upon activation, normal T-cell expressed, and secreted (RANTES) were
determined by ELISA using Quantikine kits (R&D Systems, Minneapolis, MN).
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Oil red O staining and quantification
Differentiated brown adipocytes were serum-starved overnight and were treated
with C12-iEDAP, LPS, and Pam3CSK4 for 12 h under the basal condition, or pretreated
with C12-iEDAP, LPS, Pam3CSK4, or the vehicle control for 12 h, followed by costimulated with isoproterenol (1 μM) in the presence of the ligand for another 6 h. The
cells were fixed, and lipid accumulation in brown adipocytes was stained with oil red O
(ORO) and quantified by ORO absorbance at 500 nm.
Cellular bioenergetics measurements
D6 2.5x104 brown adipocytes were subcultured and seeded in 24-well XF assay
plates overnight in the differentiation medium and subjected to real-time measurements
of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) using
XF24 Extracellular Flux Analyzer (Seahorse Biosciences, North Billerica, MA). To study
the effects of PRR ligands on bioenergetics of brown adipocytes, cells were pretreated
with C12-iEDAP (10 μg/ml), LPS (0.1 μg/ml), Pam3CSK4 (1 μg/ml), or the vehicle
control for 12 h, rinsed once, changed to 500 μl of XF assay buffer (DMEM without
NaHCO3, 10 mM glucose, 2 mM pyruvate, and 2 mM GlutaMAX, pH 7.4), and
equilibrated at non-CO2 incubator and 37°C for 1 h. Following basal measurements of
OCR and ECAR, all cells were injected either with the vehicle control or isoproterenol (1
μM) and the subsequent readings were taken over the 6 h period. At the end of the
experiment, mitochondrial complex inhibitors were injected to all treatments sequentially
in the following order: oligomycin (1 μM), carbonyl cyanideptrifluoromethoxyphenylhydrazone (FCCP; 0.75 μM), and antimycin A/rotenone (1 μM
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each), and three readings were taken after each inhibitor. OCR and ECAR were
automatically recorded by XF24 software v1.8 provided by the manufacturer.
Basal and isoproterenol-stimulated OCR and ECAR rates were determined by
averaging the measurements. Calculations of maximal OCR, ATP-coupled OCR, OCR
from proton leak, spare respiration capacity, and coupling efficiency were performed
according to the manufacturer’s instructions.
Analysis of mitochondrial content by MitoTracker green staining
Mitochondria were labeled using the mitochondria-specific dye MitoTracker
Green (Life Technologies, Carlsbad, CA) according to manufacturer’s protocol. Briefly,
the differentiated brown adipocytes were washed and trypsinized from the cultured plate
and incubated with MitoTraker green at 100 nM for 30 min at 37°C. The fluorescence
intensity was measured with Accuri C6 flow cytometry (BD, Franklin Lakes, NJ).
Background autofluorescence from nonstained cells was averaged and subtracted from
the mean fluorescence intensity values.
Statistical analysis
All data are presented as means±SE. Measurements were performed in
triplicates. Statistical analysis was performed using SigmaPlot 11.0 (Systat Software).
One-way ANOVA with repeated measures followed by multiple comparisons test
(Student-Newman-Keuls method) was performed to determine the differences between
the treatment groups and/or time points. Student’s t-tests were performed when
appropriate. The level of significance was set at P<0.05.
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2.4 Results
mRNA expression of selected PRRs is upregulated in brown fat tissue of DIO and
ob/ob mice
We first examined selected PRRs NOD1, NOD2, TLR4, and TLR2 mRNA
expression in the classical interscapular BAT from DIO and ob/ob mice, compared with
their respective controls (Figure 1A and 1B). In DIO mice, NOD1 and TLR4 were two
highly expressed PRRs, followed by NOD2 and TLR2, similar to those of their chow-fed
controls. Moreover, NOD1, TLR4, and TLR2 mRNA was significantly upregulated
(p<0.05) in DIO mice compared with their controls (Figure 1A). Similar relative
expression patterns were observed in BAT of ob/ob mice compared with their wild-type
(WT) controls (Figure 1B). Further, we examined inflammatory gene expression in BAT
from DIO and ob/ob mice. mRNA of MCP-1, IL-6 and TNF-α, but not RANTES, was
significantly upregulated in BAT of DIO mice compared with the chow-fed controls
(p<0.01 for MCP-1 and TNF- and p<0.05 for IL-6; Figure 1C). mRNA of all four genes
were significantly upregulated in BAT of ob/ob mice compared with the WT controls
(p<0.01 for MCP-1 and p<0.05 for IL-6, TNF-α, and RANTES; Figure 1D). These results
demonstrate that upregulation of selected PRRs is correlated with the upregulation of
mRNA of proinflammatory genes in BAT in mice models of obesity.
Expression of selected PRRs is upregulated during brown adipocyte
differentiation
To study the relationships between the upregulation of PRRs and inflammatory
genes in BAT, we employed an immortalized brown fat cell line generated from the
classical interscapular brown fat from C57BL6 mice (Klein et al., 2002). In vitro brown
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adipocyte differentiation was validated by the increasing mRNA expression of known
brown adipocyte markers UCP-1, PGC-1α, and PPARγ (Figure 2A, bottom). mRNA
expression of NOD1 and TLR4, but not NOD2 and TLR2, was upregulated during
differentiation (Figure.2A, top). Comparing the relative PRR expression pattern, NOD1
was the highest expressed PRR examined in brown fat cells before differentiation,
followed by TLR4 and TLR2, and NOD2 had the lowest expression. In contrast, both
NOD1 and TLR4 were among the highest expressed PRRs, followed by TLR2 and
NOD2 after differentiation (Figure 2B). Western analysis and relative quantification
confirmed that NOD1 and TLR4 were increased, whereas TLR2 was decreased upon
differentiation (Figure 2C). NOD2 protein expression was undetectable by Western
analysis (data not shown). These results suggest NOD1, TLR4, and TLR2 may be
involved in mediating inflammation and modulating functions in brown adipocytes.
PRR activation in brown adipocytes induces phosphorylation and activation of
NF-κB and MAPK signaling
Activation of PRR leads to NF-κB and MAPK signaling pathways in various PRR
expressing cells, including white adipocytes. Because of the relative higher expression
levels of NOD1, TLR4, and TLR2 than NOD2 in brown adipocytes, we focused on the
signaling pathways downstream of NOD1, TLR4, and TLR2 activation in brown
adipocytes by stimulating the cells with their respective synthetic ligands. NF-κB
pathway was activated as shown by the phosphorylation of p65 and IκBα when
stimulated with NOD1 ligand C12-iEDAP, TLR4 ligand LPS, or TLR2 ligand Pam3CSK4
in a time-dependent manner (Figure 3A). Moreover, MAPK pathways were also
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activated within 60 min after the stimulation, as shown by the phosphorylation of p38,
JNK, and ERK when stimulated with C12-iEDAP, LPS, or Pam3CSK4 (Figure 3A).
We further confirmed that activation of NOD1, TLR4, and TLR2 induced NF-κB
activation with NF-κB-responsive luciferase reporter assays in brown adipocytes by
transiently infecting the brown adipocytes with the adenovirus encoding NF-κB-Luc
receptor gene. Activation of NOD1, TLR4, and TLR2 dose-dependently induced NF-κB
reporter activation (Figure 3B). In contrast, NOD2 ligand MDP induced minimal NF-κB
activation even when used up to 100 μg/ml in brown adipocytes (data not shown).
PRR activation in brown adipocytes upregulates the mRNA expression and
protein secretion of proinflammatory cytokines/chemokines
Consequently, we found that activation of NOD1, TLR4, and TLR2 significantly
increased mRNA expression of chemokine MCP-1, cytokine IL-6, RANTES, and tumor
necrosis factor alpha (TNF-α; p<0.01 or p<0.05; Figure 4A). Other than TNF- α, which
was below detection limit, protein secretion in the supernatant of the brown adipocytes
was confirmed for MCP-1, IL-6, and RANTES by ELISA (Figure 4B).
Inhibitory of the NF-κB or MAPK pathways differentially attenuates
proinflammatory mRNA expression in brown adipocytes
To determine if NF-κB or MAPK signaling pathway underlies proinflammatory
cytokine or chemokine mRNA expression, we examined the effects of the
pharmacological inhibitors of these pathways on mRNA expression on the
cytokines/chemokines. NF-κB inhibitor QNZ (Tobe et al., 2003) and CAPE (Natarajan,
Singh, Burke, Grunberger, & Aggarwal, 1996) significantly attenuated C12-iEDAP, LPS
or Pam3CSK4-induced MCP-1, IL-6, RANTES, and TNF-α in brown adipocytes (Figure
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5), suggesting NF-κB pathway is involved in NOD1-, TLR4-, or TLR2-mediated
inflammatory cytokine/chemokine expression.
Among the inhibitors of MAPKs, only the p38 inhibitor SB203580 significantly
attenuated C12-iEDAP-induced MCP-1, IL-6, TNF-α, and RANTES mRNA expression
(Figure 6). In contrast, the JNK inhibitor SP600125 significantly attenuated LPS-induced
all four mRNA. The ERK inhibitor PD98054 significantly attenuated LPS-induced IL-6,
TNF-α, and RANTES mRNA, but not MCP-1 mRNA, whereas the p38 inhibitor
SB203580 did not affect any of the four mRNA induced by LPS. The p38 inhibitor
SB203580 significantly attenuated Pam3CSK4-induced IL-6 and RANTES mRNA, and
the ERK inhibitor PD98054 only attenuated Pam3CSK4-induced MCP-1 and IL-6
mRNA, whereas the JNK inhibitor SP600125 attenuated Pam3CSK4-induced MCP-1,
TNF-α, RANTES, but not IL-6 (Figure 6).
PRR activation suppresses both basal and isoproterenol-inducted UCP-1
expression, but not mitochondrial biogenesis, in brown adipocytes
The main function of brown adipocytes is mediated by UCP-1 to uncouple
oxidative phosphorylation from ATP synthesis to produce heat and UCP-1 is known to
be predominantly regulated at transcriptional level (Richard & Picard, 2011). We next
examined whether PRR activation in brown adipocytes affects UCP-1 mRNA
expression. Activation of NOD1, TLR4, and TLR2 suppressed both basal and
isoproterenol, a nonspecific β-adrenergic agonist, -induced UCP-1 mRNA expression
(Figure 7A). We also examined other brown adipocyte markers. Similar suppression
was observed for cell-death inducing DFFA-like effector a (Cidea), and distinct but
different changes were observed for PGC-1α and PPARγ. PPARγ mRNA was
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suppressed by activation of NOD1, TLR4, or TLR2 under basal and isoproterenol induced conditions. In contrast, PGC-1α mRNA was only suppressed by the activation
of the PRR under the basal condition. Moreover, no changes were observed for nuclear
respiratory factor 1 (Nrf1) and transcription factor A (Tfam), and two nucleus encoded
mitochondrial genes, cytochrome c oxidase subunit IV a (COX4a) and cytochrome bc1complex subunit 6 (Uqcrh) (Figure 7A). Western analysis and relative quantification
confirmed that UCP-1 expression was suppressed by the activation of NOD1, TLR4,
and TLR2 in brown adipocytes under both conditions but more pronounced under
isoproterenol-stimulated condition (Figure 7B). PPARγ protein expression was markedly
suppressed by the PRR activation under both conditions, similar to that of PPARγ
mRNA. In contrast, the PGC-1α protein was not affected by PRR activation under both
conditions in brown adipocytes. We further examined the effects of PRR activation on
brown adipocyte cell morphology and lipid accumulation. Under our experimental
conditions, there were no significant changes in cell morphology (data not shown) and
lipid accumulation, revealed by ORO staining, by the activation of NOD1, TLR4, or
TLR2 under both conditions (Figure 7C).
To test whether suppression of UCP-1 mRNA by PRR activation is a direct effect
on the UCP-1 promoter or due to the effects on mitochondrial biogenesis, we performed
UCP-1 promoter-driven reporter assays and confirmed that the effects of PRR activation
was via suppressing UCP-1 promoter activities (Figure 7D). Consistent with the above
mRNA expression results, PRR activation did not affect mitochondrial biogenesis as
revealed by the staining of mitochondrial specific fluorescence mitoTracker Green
(Figure 7E). Taken together, these results suggest that PRR activation in brown
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adipocytes suppresses both basal and isoproterenol-induced UCP-1 expression at least
in part through downregulation of the UCP-1 promoter, but not through modulation of
mitochondrial biogenesis.
PRR activation suppresses mitochondrial respiration in brown adipocytes
To further determine whether the suppression of UCP-1 by PRR activation leads
to changes in mitochondrial respiration, we performed cellular bioenergetics
measurements in brown adipocytes using XF24 Extracellular Flux Analyzers (Figure 8).
It has been determined that the activation of NOD1, TLR4, TLR2 did not change cell
viability as measured by the MTT assays (data not shown). The basal oxygen
consumption rate (OCR) of brown adipocytes was 109±10.02 pM/min, which was
suppressed to 93±8.4, 79.9±5.5, and 82.5±9.79 pM/min by C12-iEDAP (p<0.05), LPS
(p<0.01), and Pam3CSK4 (p<0.01), respectively (Figure 8C). Injection of isoproterenol
(1 μM) resulted in a gradual increase in OCR that peaked at 142.2±21.1 pM/min
(p<0.05), which was significantly reduced to 99.3±10, 92±8.7, and 76.8±3.4 pM/min by
C12-iEDAP (p<0.05), LPS (p<0.01), and Pam3CSK4 (p<0.01), respectively (Figure 8C).
The ECAR, an indirect measure of glycolysis and lactate production, was measured
simultaneously with OCR. Brown adipocytes treated with C12-iEDAP (p<0.05), LPS
(p<0.01), and Pam3CSK4 (p<0.05) all showed a significant increase in basal ECAR,
with LPS inducing the highest level. Injection of isoproterenol induced a modest but
significant increase in ECAR over the baseline (p<0.05); however, both C12-iEDAP and
Pam3CSK4 significantly suppressed isoproterenol-induced ECARs (p<0.05). LPS
induced a suppressive, but not significant, trend on isoproterenol-induced ECAR (Figure
8D).
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Further calculations revealed that PRR activation did not affect isoproterenolinduced maximal respiration (Figure 8E) and ATP-generating OCR (Figure 8F), but
significantly suppressed isoproterenol-induced uncoupled OCR from proton leak (Figure
8G) and increased coupling efficiency (Figure 8H). Taken together, these results show
that PRR activation significantly attenuates basal and isoproterenol-induced OCR and
isoproterenol-induced uncoupled respiration from proton leak, but does not affect
maximal respiration and ATP-coupled respiration, consistent with the suppressive
effects of PRR activation on UCP-1 expression in brown adipocytes.
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2.5 Discussion
It has been well recognized that obesity is associated with chronic inflammation,
both systemically and locally in WAT. Here we report, for the first time, that mRNA of
major PRR NOD1, TLR4, and TLR2, but not NOD2, was upregulated in BAT, which was
paralleled by the mRNA expression of the inflammatory chemokine MCP-1 and
cytokines IL-6 and TNF-α in both DIO and ob/ob mice compared with their respective
controls (Figure 1). Using an immortalized brown cell line derived from the classical
interscapular BAT, we show that both mRNA expression and protein expression of
NOD1 and TLR4, but not NOD2 or TLR2, were increased upon brown adipocyte
differentiation (Figure 2); the activation of NOD1, TLR4, and TLR2 induced activation of
the NF-κB and MAPK signaling pathways (Figure 3), leading to upregulation of mRNA
and/or protein expression of the proinflammatory gene MCP-1, IL-6, RANTES, and
TNF-α, in the cultured brown adipocytes (Figure 4-6). Moreover, activation of these
PRRs in the brown adipocytes suppressed basal and isoproterenol-induced UCP-1
mRNA and protein expression (Figure 7A and B), at least in part through suppressing
UCP-1 promoter activities (Figure 7D). Further, PRR activation suppressed both basal
and isoproterenol-induced oxygen consumption rates (Figure 8C), and isoproterenolinduced uncoupled respiration from proton leaks (Figure 8G) and increased coupling
efficiency (Figure 8H), but did not affect the maximal respiration (Figure 8E) and ATPgenerating respiration (Figure 8F).
BAT has emerged as a novel target for obesity treatment and prevention, due to
its unique role in energy expenditure. Two sources of brown adipocytes have been
identified. One is from classical BAT depots, such as interscapular region, the other one
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is from UCP-1 expressing, brown-like adipocytes from WAT depots, such as
subcutaneous depot. While it is still unclear about the formation of the brown-like
adipocytes in typical WAT, it is less debated that classical brown adipocytes share a
common progenitor with skeletal muscle, different from that of brown-like adipocytes
from WAT. The findings that adult humans do have classical BAT argue for research on
classical BAT depots in rodents as they also have relevance to human physiology
(Nedergaard & Cannon, 2013). To our knowledge, this is the first report demonstrating
that the upregulation of mRNA expression of the selected PRRs in the classical BAT in
obesity and the regulation of PRR expression at both mRNA and protein levels in
differentiating brown adipocytes in culture. Our report further shows that activation of
selected PRRs induces the proinflammatory response and suppresses UCP-1
expression, which are accompanied by attenuated mitochondrial respiration in cultured
brown adipocytes. Our results suggest that PRR-mediated inflammation in BAT may be
targets for modulation of brown adipose function to combat against obesity.
It is well recognized that PRRs are capable of sensing the disturbance from not
only the immune system but also metabolism, the homeostasis of both processes is
important for the survival of the organisms (Hotamisligil & Erbay, 2008; Jin et al., 2013).
It is believed that the disturbances in obesity, i.e., the ligands for the PRRs, are excess
of nutrients e.g., saturated fatty acids (Könner & Brüning, 2011), production of
endogenous molecules from metabolic stress and tissue injuries e.g., ceramides
(Fischer et al., 2007), and high mobility group box 1 (Li et al., 2011), or modulation of
intestinal microbiota (Cani et al., 2007; Nicholson et al., 2012). Whether these ligands
activate PRR in BAT in obesity remains to be determined in the future.
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Mouse models of global deficiency of the PRRs have been instrumental in
determining the role of PRRs in linking inflammation and metabolic stress. The effects
of global deficiency of TLR4 and TLR2 on DIO, tissue inflammation, and insulin
resistance have been reported (Davis et al., 2011; Ehses et al., 2010; Himes & Smith,
2010; Shi et al., 2006; Tsukumo et al., 2007). Shi et al. (Shi et al., 2006) reported that
only female mice lacking TLR4 were partially protected from high-fat DIO and insulin
resistance, accompanied by less inflammation in the liver and fat (with no specification
of fat type) compared with the WT control mice; however, energy expenditure was not
reported. Male C3H/HeJ mice, which have a loss-of-function mutation in TLR4, were
reported to be protected against the development of DIO with increased oxygen
consumption (indicating the increased metabolic rate), and decreased respiratory
exchange ratio (indicating the preferential use of fat as an energy source), improved
insulin sensitivity, and enhanced insulin-signaling in white adipose tissue, muscle, and
liver, compared with the controls. Inflammation of brown adipose was not reported in
this study (Tsukumo et al., 2007). Moreover, global TLR2 deficiency protected the mice
from DIO (Ehses et al., 2010; Himes & Smith, 2010; Kuo et al., 2011), liver, muscle
(Ehses et al., 2010; Kuo et al., 2011), and pancreatic β-cells (Ehses et al., 2010). TLR2deficient mice showed an increase in energy expenditure as measured by oxygen
consumption (VO2) in the dark cycle (Ehses et al., 2010; Kuo et al., 2011). In these
studies, inflammation in BAT was not reported. Furthermore, mice with double knockout
of NOD1 and NOD2 were shown to be protected from high-fat DIO, insulin resistance,
inflammation in the white adipose and the liver (Schertzer et al., 2011). Energy
expenditure and inflammation in brown adipose were not reported in this study
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(Schertzer et al., 2011). Therefore, the role of PRR-mediated inflammation in BAT in
diet-induced systemic inflammation, insulin resistance, and altered energy expenditure
in obesity remains to be determined.
Our results show that mRNA of selected PRR (NOD1, TLR4, TLR2, and NOD2)
was upregulated in BAT in obesity, which correlated with increased mRNA expression
of proinflammatory cytokines/chemokines, i.e., MCP-1, IL-6, TNF-α, and RANTES
(Figure 1). MCP-1 has been reported to be a critical chemotactic factor for macrophage
infiltration into the adipose tissue, leading to adipose inflammation (Kamei et al., 2006;
Kanda et al., 2006). TNF-α and IL-6 are known cytokines that induce insulin resistance
in skeletal muscle and liver (Rasouli & Kern, 2008). RANTES has also been reported to
be upregulated and is associated with T-cell accumulation in murine and human obesity
(Wu et al., 2007). Activation of NOD1, TLR4, and TLR2 is capable of inducing MCP-1,
IL-6, RANTES, and TNF-α mRNA as well as protein secretion (except for TNF-α, which
is below detection limit) in brown adipocytes (Figure 4). The differences in patterns
between protein secretion and mRNA expression downstream of PRRs may reflect the
differences in posttranscriptional modulation of those cytokines/chemokines
downstream of the PRR activation in brown adipocytes. Using pharmacological
inhibitors of NF-κB and MAPK, we show these pathways were differentially involved in
mRNA expression of MCP-1, IL-6, TNF-α, and RANTES downstream of NOD1, TLR4,
and TLR2 (Figure 5 and 6). While the NF-κB pathway appeared to be involved in all four
examined cytokines/chemokines induced by C12-iEDAP, LPS, or Pam3CSK4, the
involvement of MAPK seemed to differ among the activation of NOD1, TLR4, and TLR2.
NOD1 activation primarily induced p38 MAPK as inhibition of p38 MAPK, but not other
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MAPKs, attenuated mRNA of all four cytokines/chemokines. In contrast, differential yet
distinct involvements of MAPKs downstream of activation of TLR4 and TLR2 were
noted in brown adipocytes. The JNK inhibitor SP600125 significantly attenuated,
whereas the p38 inhibitor SB203580 did not affect the mRNA of the four
proinflammatory genes induced by LPS. The ERK inhibitor PD98054 significantly
attenuated LPS-induced IL-6, TNF-α, and RANTES mRNA, but not MCP-1 mRNA. On
the other hand, the JNK inhibitor SP600125 attenuated Pam3CSK4-induced mRNA of
MCP-1, TNF-α, RANTES, but not IL-6, whereas the p38 inhibitor SB203580 only
significantly attenuated Pam3CSK4-induced IL-6 and RANTES mRNA and the ERK
inhibitor PD98054 only attenuated Pam3CSK4-induced MCP-1 and IL-6 mRNA. That
distinct intracellular signaling pathways downstream of various PRRs control
cytokines/chemokine expression, which has been reported in other cell types (Kopp et
al., 2009; Natarajan et al., 1996), make it possible to design specific strategies to target
individual PRR or cytokine/chemokine for the benefits of enhancing the functions of
brown adipocytes.
Moreover, our results demonstrate that PRR activation led to down-regulation of
both basal and isoproterenol-stimulated UCP-1 mRNA as well as protein expression
with more pronounced suppression under isoproterenol-stimulated condition (Figure 7A
and B). These were accompanied by attenuated basal and isoproterenol-stimulated
oxygen consumption and uncoupled respiration from proton leaks, but not maximal
respiration and ATP-generated respiration (Figure 8). Initial mechanistic studies show
that PRR-mediated downregulation of UCP-1 mRNA was not due to suppression of
mitochondrial biogenesis as there were no changes in mRNA of two other mitochondrial
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genes (COX4a and Uqcrh) (Figure 7A) and no changes of mitochondrial biogenesis by
mitoTracker staining (Figure 7E). In contrast, similar degrees of suppression of UCP-1
promoter activities were observed (Figure 8D). Taken together, these results
demonstrate that PRR activation suppresses UCP-1 expression, leading to attenuated
mitochondrial respiration, via at least in part down regulation of UCP-1 promoter
activities. One of the possible mechanisms for PRR-mediated suppression of UCP-1
promoter is through NF-κB pathway, since we have shown that PRR activation leads to
NF-κB activation in brown adipocytes, and a few putative NF-κB transcriptional factor
binding sites have been identified upstream of the transcription start site using
bioinformatics tools. The molecular mechanisms underlying the cross talk between NFκB pathway downstream of PRR activation and UCP-1 transcription under the basal or
β-adrenergic stimulation need to be explored further.
Compared with UCP-1 expression, PRR activation at the same time also
differentially affected PPARγ and PGC-1α expression, both of which are important for
the expression of brown adipocyte markers, such as UCP-1. Evidence has emerged
from studies that PPARγ not only controls white adipocyte differentiation but also
controls brown adipocyte differentiation (Gray et al., 2006; Petrovic, Shabalina,
Timmons, Cannon, & Nedergaard, 2008; Sell et al., 2004). PGC-1α coactivates
transcription factor PPARγ bound to the rpomoters of target genes, such as UCP-1, to
control gene transcription (Puigserver et al., 1998; Tiraby et al., 2003). The results show
PRR activation suppressed both PPARγ mRNA and protein expression under the basal
and isoproterenol-stimulated conditions whereas PRR activation only suppressed PGC1α mRNA under the basal condition, but did not suppress PGC-1α protein under both
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conditions (Figure 7A and B). The differences between mRNA and protein expression of
PGC-1α may be due to the protein stability. Moreover, we also examined the brown
adipocyte cell morphology and lipid accumulation under the same conditions. Both the
cell morphology (data not shown) and lipid accumulation by ORO staining and
quantification (Figure 7C) did not seem to be affected by PRR activation. Taken
together, our results demonstrate that PRR activation in differentiated brown adipocytes
selectively suppressed UCP-1 and some other brown adipocyte markers expression
(e.g., PPARγ and Cidea) without affecting mitochondrial biogenesis and lipid
accumulation, which is sufficient to lead to suppressed mitochondrial oxygen
consumption and uncoupled respiration.
In summary, we have demonstrated the role of selected PRRs in mediating
inflammation and downregulation of UCP-1 expression without affecting mitochondrial
biogenesis and lipid accumulation, leading to suppressed mitochondrial respiration in
the classical brown adipocytes. Our results suggest that PRR-mediated inflammation in
brown adipocytes may be potential targets to modulate BAT function for obesity
treatment and prevention.
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Figure 1 mRNA expression of selected PRRs are up-regulated in brown fat tissue
of DIO and ob/ob mice
mRNA expression of NOD1, NOD2, TLR4 and TLR2 (A, B) and proinflammatory
chemokines/cytokines (MCP-1, IL-6, RANTES, TNF-α) (C, D) in the interscapular brown
fat tissue from the DIO male mice (n=7) (A, C) or ob/ob male mice (n=6), and their
respective controls were evaluated by semi-quantitative RT-PCR. The relative mRNA
expression was normalized to 36B4 and expressed as fold of the value of TLR2 in chow
fed or wt group (set as 1). a-d are for Chow or WT groups (solid bars); a’-c’ are for DIO
or Ob/Ob groups (gray bars). Different letters indicate significant differences among
solid or gray bars. *p<0.05, **p<0.01, significantly different from the controls.
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Figure 2 Expression of selected PRRs are up-regulated during brown adipocyte
differentiation
Brown fat cells were differentiated as described in Materials and Methods. Total RNA
was isolated at confluency (D0), 2 (D2), 4 (D4), and 6 day (D6) post initiation of
differentiation. (A) mRNA expression of NOD1, NOD2, TLR4, and TLR2 and brown
adipocyte markers PGC-1α, PPARγ, and UCP-1 was evaluated by semi-quantitative
RT-PCR. The relative mRNA expression was normalized to 36B4 and expressed as fold
of D0 value (set as 1). (B) Relative mRNA expression of NOD1, NOD2, TLR4, and
TLR2 before differentiation (D0) and after differentiation (D6) was compared. The
relative mRNA expression was normalized to 36B4 and expressed as fold of NOD2
value (set as 1). (C) Protein expression of NOD1, TLR4, and TLR2 was analyzed at D0,
2, 4, and 6 by western analysis with primary antibodies against NOD1, TLR4, and
TLR2. ERK1/2 protein was used as a loading control. This experiment has been
performed independently three times, and the representative results are shown (left).
Relative quantification of western analysis was done by densitometry. The data are
expressed as fold to the D0 level (set as 1) (right). Data are means±SE (n=3). Different
letters indicate significant differences between bars. *p<0.05, **p<0.01, significantly
different from the controls.
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Figure 3 PRR activation in brown adipocytes induces phosphorylation and
activation of NF-κB and MAPK signaling
(A) Brown adipocytes were serum starved overnight and were stimulated with C12iEDAP (10 µg/ml), LPS (1 µg/ml), Pam3CSK4 (10 µg/ml) or the vehicle control for
indicated times, and whole cell lysate was prepared and analyzed by western analysis
with specific antibodies against phospho-p65, phospho-IκBα, phospho-p38, phosphoJNK, phospho-ERK, p65, p38, JNK and ERK. (B) Brown adipocytes were infected with
adenovirus encoded NF-κB-Luc and β-galactosidase for 24 h and stimulated with
increasing doses of C12-iEDAP, LPS, or Pam3CSK4 as indicated for 18 h. Reporter
gene assays were performed. Relative luciferase activities were normalized by βgalactosidase activities for each sample and expressed as fold of the vehicle value (set
as 1). Data are means±SE (n=3). **p<0.01, significantly different from the controls.
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Figure 4 PRR activation in brown adipocytes up-regulates the expression and
secretion of proinflammatory cytokines/chemokines
Brown adipocytes were stimulated with C12-iEDAP (10 µg/ml), LPS (0.1 µg/ml),
Pam3CSK4 (1 µg/ml), or the vehicle control for 12 h. Total RNA was isolated for mRNA
expression of MCP-1, IL-6, RANTES, TNF-α by semi-quantitative RT-PCR (A), and the
supernatant was collected for protein measurements of MCP-1, IL-6, RANTES by
ELISA (B). Data are means±SE (n=3). *p<0.05, **p<0.01, significantly different from the
controls.
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Figure 5 Inhibition of NF-κB attenuates mRNA expression of proinflammatory
cytokines/chemokines induced by PRR activation
Brown adipocytes were pretreated with NF-κB inhibitor QNZ (20 nM) and CAPE (10 µM)
for 1 h and costimulated with C12-iEDAP (10 µg/ml), LPS (0.1 µg/ml), Pam3CSK4 (1
µg/ml), or the vehicle control. mRNA expression of MCP-1, IL-6, RANTES, and TNF-α
was evaluated by semi-quantitative RT-PCR. The relative mRNA expression was
normalized to 36B4 and expressed as fold of the vehicle value (set as 1). Data are
means±SE (n=3). *p<0.05, **p<0.01, significantly different from the controls.
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Figure 6 Inhibition of MAPK differentially attenuates mRNA expression of
proinflammatory cytokines/chemokines induced by PRR activation
Brown adipocytes were pretreated with ERK inhibitor PD98054 (10 µM), JNK inhibitor
SP600125 (10 µM), or p38 inhibitor SB203580 (2 µM) for 1 h and costimulated with
C12-iEDAP (10 µg/ml), LPS (0.1 µg/ml), Pam3CSK4 (1 µg/ml) or the vehicle control.
mRNA expression of MCP-1, IL-6, RANTES, and TNF-α was evaluated by semiquantitative RT-PCR. The relative mRNA expression was normalized to 36B4 and
expressed as fold of the vehicle value (set as 1). Data are means±SE (n=3). *p<0.05,
**p<0.01, significantly different from the controls.
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Figure 7 PRR activation suppresses both basal and isoproterenol-induced UCP-1
expression, but not mitochondrial biogenesis, in brown adipocytes
(A) Brown adipocytes were serum starved with 1% charcoal-dextran stripped FBS
containing DMEM for overnight. The cells were pretreated with C12-iEDAP (10 µg/ml),
LPS (0.1 µg/ml), Pam3CSK4 (1 µg/ml), or the vehicle control for 1 h followed by
costimulated with or without isoproterenol (ISO, 1 µM) in the presence of the ligand for 6
h. mRNA of UCP-1 and other marker genes was evaluated by semi-quantitative RTPCR. Relative gene expression was normalized to 36B4 and expressed as fold of the
vehicle value (set as 1). (B, C) Brown adipocytes were serum starved overnight, and
were treated with C12-iEDAP, LPS, and Pam3CSK4 for 12 h under the basal condition,
or pretreated with C12-iEDAP, LPS, Pam3CSK4, or the vehicle control for 12 h,
followed by costimulated with ISO in the presence of the ligand for another 6 h. Whole
cell lysate was prepared from one set of cell samples and analyzed by western analysis
with antibody against of UCP-1, PPARγ, and PGC-1α. ERK1/2 protein was used as a
loading control. This experiment has been performed independently three times and the
representative results are shown (left). Relative quantification of western analysis was
done by densitometry. The data are expressed as fold to the level of the vehicle control
(-) under basal condition (set as 1) (right). A duplicate set of cell samples were fixed and
stained with oil red O (ORO) for lipid accumulation, and ORO absorbance at 500 nm is
shown in C. (D) Brown adipocytes were subcultured and transiently transfected with
mouse UCP-1-Luc together with β-galactosidase plasmid. The cells were pretreated
with C12-iEDAP (10 µg/ml), LPS (0.1 µg/ml), Pam3CSK4 (1 µg/ml), or the vehicle
control for 1 h followed by costimulation of the ligand with or without ISO for 15 h.
Reporter gene assays were performed. Relative luciferase activities were normalized by
β-galactosidase activities for each sample and expressed as fold of the vehicle value
(set as 1). (E) Brown adipocytes were treated with C12-iEDAP (10 µg/ml), LPS (0.1
µg/ml), Pam3CSK4 (1 µg/ml), or the vehicle control for 12 h. The cells were washed
with PBS and stained with MitoTracker green (100 nM) for 30 min at 37 0C. The
fluorescence intensities were measured as described in Materials and Methods. Data
are means±SE (n=3). *p<0.05, **p<0.01, significantly different from the controls.
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Figure 8 PRR activation suppresses mitochondrial respiration in brown
adipocytes
(A, B) Brown adipocytes were subcultured and seeded in 24-well XF assay plates
overnight and were pretreated with LPS (0.1 μg/ml), Pam3CSK4 (1 μg/ml), C12-iEDAP
(10 μg/ml), or the vehicle control for 12 h and were then subjected to real-time
measurements of oxygen consumption rate (OCR) and extracellular acidification rate
(ECAR). Following the basal measurements, all cells were injected either with the
vehicle control or ISO (1 μM). In each experiment, mitochondrial complex inhibitors
were injected to all treatments sequentially in the following order: oligomycin (1 μM),
carbonyl cyanide-ptrifluoromethoxyphenylhydrazone (FCCP; 0.75 μM), antimycin
A/rotenone (1 μM each), and the readings were taken after each inhibitor. The OCR (A)
and ECAR (B) readings were plotted over time. Basal and ISO-induced OCR (C) and
ECAR (D) is shown. ISO-induced maximal OCR (E), OCR from ATP production (F),
OCR from proton leak (G), and coupling efficiency (H) are also shown. Data are
means±SE (n=6-9). *p<0.05, **p<0.01, significantly different from the controls.
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CHAPTER III
CHRONIC ACTIVATION OF PATTERN RECOGNITION RECEPTORS
SUPPRESSES BROWN ADIPOGENESIS OF MULTIPOTENT
MESODERMAL STEM CELLS AND BROWN PRE-ADIPOCYTES
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A version of this chapter was originally published by Jiyoung Bae, Jiangang
Chen, Ling Zhao entitled “Chronic activation of pattern recognition receptors suppresses
brown adipogenesis of multipotent mesodermal stem cells and brown pre-adipocytes”
Biochemistry and Cell Biology 93(3): 251-261 (2015).
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3.1 Abstract
Brown adipose tissue (BAT) holds promise to combat obesity through energyspending, non-shivering thermogenesis. Understanding of regulation of BAT
development can lead to novel strategies to increase BAT mass and function for obesity
treatment and prevention. Here, we report the effects of chronic activation of PRR on
brown adipogenesis of multipotent mesodermal stem C3H10T1/2 cells and immortalized
brown pre-adipocytes from the classical interscapular BAT of mice. Activation of NOD1,
TLR4, or TLR2 by their respective synthetic ligand suppressed brown marker gene
expression and lipid accumulation during differentiation of brown-like adipocytes of
C3H10T1/2. Activation of the PRR only during the commitment was sufficient to
suppress the differentiation. PRR activation suppressed PGC-1α mRNA, but induced
PRDM16 mRNA at the commitment. Consistently, PRR activation suppressed the
differentiation of immortalized brown pre-adipocytes. Activation of PRR induced NF-κB
activation in both cells, which correlated with their abilities to suppress PPARγ
transactivation, a critical event for brown adipogenesis. Taken together, our results
demonstrate that chronic PRR activation suppressed brown adipogenesis of multipotent
mesodermal stem cells and brown pre-adipocytes, possibly through suppression of
PPARγ transactivation. The results suggest that anti- inflammatory therapies targeting
PRRs may be beneficial for the BAT development.
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3.2 Introduction
Obesity is one of the main public health concerns all over the world. Obesity is
associated with chronic inflammation, which is considered to be the starting point for the
progression of obesity associated comorbidities, such as insulin resistance and type 2
diabetes. Evidence suggests that pattern recognition receptors (PRR) play critical roles
in obesity associated inflammation (Jin et al. 2013). Toll-like receptors (TLR) and
nucleotide-oligomerization domain containing protein-like receptor (NLR) are two
families of PRRs that play critical roles in innate immune response and inflammation.
TLRs are membrane-bound receptors, predominantly sensing microbe- or host-derived
insults in the extracellular or endosomal compartments, whereas NLRs are cytosolic
receptors, sensing invading intracellular pathogens and intracellular perturbations
associated with stress or damage (Kawai and Akira 2009; Takeuchi and Akira 2010).
TLRs are composed of extracellular leucine-rich repeat motifs and a cytoplasmic
Toll/interleukin-1 receptor (TIR) homology domain. Out of the 10 and 12 functional TLRs
identified in humans and mice, respectively, several TLRs, TLR4 and TLR2 in particular,
have been implicated in adipose inflammation in diet-induced obesity (Shi et al. 2006;
Tsukumo et al. 2007; Himes and Smith 2009; Ehses et al. 2010; Davis et al. 2011).
NLRs are composed of a central nucleotide-binding domain, an N-terminal protein
interaction domain, and a C-terminal leucine-rich repeat domain (Chen et al. 2009).
NOD1 and NOD2 are two prominent members of NLRs. Activation of NOD1 has been
shown to induce inflammation in white adipocytes (Zhao et al. 2011) and adipose
inflammation and insulin resistance in mice (Schertzer et al. 2011). Activation of PRR
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triggers proinflammatory signaling pathways, including NF-κB activation, leading to
innate immune response in immune as well as non-immune cells.
Brown adipose tissue (BAT) has gained increasing attention due to recent
findings of brown fat depots in the cervical, supraclavicular, and paraspinal regions of
adult humans (Cypess et al. 2009; Saito et al. 2009; van Marken Lichtenbelt et al. 2009;
Virtanen et al. 2009; Zingaretti et al. 2009). In contrast to energy-storing role for white
adipocytes, brown adipocytes are responsible for energy expenditure through nonshivering thermogenesis. The thermogenic property of brown adipocytes is conferred
mainly by the function of uncoupling protein 1 (UCP-1), uniquely expressed in the inner
membrane of the enriched mitochondria to uncouple ATP synthesis from respiration,
leading to heat production (Nicholls and Locke 1984; Ricquier 2005). Therefore, BAT
has become a novel target for obesity treatment and prevention. Understanding of the
regulation of BAT development by both positive and negative regulators hold great
promise to lead to novel strategies to increase BAT mass and function to combat
obesity (Vijgen and van Marken Lichtenbelt 2013; Vosselman et al. 2013).
We have reported that TLR4, TLR2, and NOD1 are expressed and functional in
BAT of mice and/or brown adipocytes (Bae et al. 2014). Acute activation of the PRR (<
24hr) in mature brown adipocytes induces proinflammatory response, leading to
suppression of UCP-1 expression and mitochondrial respiration. However, the effects of
chronic activation of PRR on in vitro brown adipogenesis have not been studied. Here
we report that the effects of chronic PRR activation on brown adipocyte differentiation
using two well-studied cellular models of brown adipogenesis: multipotent mesodermal
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stem C3H10T1/2 cells and brown pre-adipocytes derived from immortalized stromal
cells from interscapular BAT of mice.
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3.3 Materials and methods
Reagents
Recombinant human bone morphogenic protein 4 (BMP4) was purchased from
R&D Systems (Minneapolis, MN). NOD1 synthetic ligand lauroyl-γ-D-Glu-mesodiaminopimelic acid (C12-iEDAP) and TLR2 ligand a synthetic triacylated lipoprotein
Pam3CSK4 were purchased from Invivogen (San Diego, CA). Ultra pure TLR4 ligand
lipopolysaccharide (LPS) was purchased from List Biological Laboratories (Campbell,
CA). Fetal bovine serum (FBS) was purchased from Atlas Biologicals (Fort Collins, CO).
Dulbecco’s modified Eagle’s medium (DMEM), 3-isobutyl-L-methylxanthine, T3,
dexamethasone, insulin, indomethacin, and anti-UCP-1 antibody were purchased from
Sigma-Aldrich (St. Louis, MO). Antibodies anti-ERK1/2 (#4695) and anti-PPARγ (#2443)
were purchased from Cell signaling Technology (Danvers, MA). Anti-PGC-1 antibody
(AB3242) was purchased from Millipore (Temecula, CA). Pharmacological inhibitor of
NF-κB caffeic acid phenethyl ester (CAPE) was purchased from Tocris Bioscience
(Ellisville, MI).
Cell culture and brown differentiation
Mouse multipotent mesodermal stem C3H10T1/2 cells were purchased from
American Type Culture Collection (ATCC, Manassas, VA). Immortalized brown
preadipocyte cell line, derived from the interscapular brown fat of 6-7 weeks old of
C57BL mice, is a generous gift from Dr. Johannes Klein (University of Lubeck,
Germany) (Klein et al. 2002). C3H10T1/2 cells were maintained in DMEM
supplemented with 10% FBS (Atlas biological, Fort Collins, CO) and brown
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preadipocytes were maintained in DMEM supplemented with 20% FBS. Both were
grown at 37°C humidified atmosphere of 5% CO2 in air.
The differentiation of brown-like adipocytes from C3H10T1/2 cells was essentially
as described (Xue et al. 2014). C3H10T1/2 cells were plated into 20% confluence (day 5 or D-5). On the second day, the cells were treated with BMP4 (20 ng/mL) for 5 days
until they reach confluency (day 0 or D0). On D0, the cells were changed into DMEM
supplemented with 20% FBS, 1 nM/L T3, 20 nM/L insulin, 0.125 mM/L indomethacin, 5
μM/L dexamethasone, and 0.5 mM/L 3-isobutyl-L-methylxanthine for 24 h, followed by
DMEM supplemented with 20% FBS, 1 nM/L T3, and 20 nM/L insulin, replenished every
two days until the cells were fully differentiated at day 6 (D6). The differentiation of
brown pre-adipocytes was as previously described (Bae et al. 2014). The cells were
plated and grown in DMEM supplemented with 20% FBS until confluency (designed as
D0). The cells were then changed into DMEM supplemented with 20% FBS, 1 nM/L T3,
20 nM/L insulin, 0.125 mM/L indomethacin, 5 μM/L dexamethasone, and 0.5 mM/L 3isobutyl-L-methylxanthine for 24 h, followed by DMEM supplemented with 20% FBS, 1
nM/L T3, and 20 nM/L insulin, replenished every two days until the cells were fully
differentiated at day 6 (D6).
The synthetic PRR ligand C12-iEDAP, LPS, Pam3CSK or the vehicle control was
added to the media as indicated in the figures and figure legends. The ligands were
replaced with each change of the media during the process, as indicated.
Western blot analysis
Total cell lysates were prepared and protein concentrations were determined by
BCA assay kit (Thermo Scientific, Waltham, MA). Thirty micrograms of total cell lysates
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were subjected to 10% SDS-PAGE and transferred to polyvinylidene difluoride
membrane (Bio-Rad, Hercules, CA). The membrane was incubated with 5% nonfat milk
blocking solution containing 20 mM/L Tris-HCl, 137 mM/L NaCl, and 0.1% Tween 20
(pH 7.4). The membrane was immunoblotted with primary antibodies at 4°C for
overnight followed by secondary antibody conjugated with horseradish peroxidase (GE
Healthcare). The signals were developed by enhanced chemiluminescence method
(Thermo Scientific, Rockford, IL).
RNA preparation and quantitative real-time PCR analysis
Total RNA was prepared using TRI reagent (Molecular Research Center,
Cincinnati, OH). Total RNA abundance was quantified using a NanoDrop ND-1000
Spectrophotometer (NanoDrop Technologies, Wilmington, DE). Reverse transcription
was carried out using Fermentas first strand synthesis kit (Thermo Scientific, Pittsburgh,
PA) according to the manufacturer’s instruction. mRNA expression of indicated genes
and loading control 36B4 (an uncharacterized large riobosomal protein) gene were
measured quantitatively using gene-specific primers, and PCR was run in a 96-well
plate using an ABI 7300HT instrument. Cycle conditions were 50 0C 2min, 95 0C 15 min,
then 40 cycles of 95 0C for 15 s/60 0C for 1 min. Relative gene expression was
calculated using the 2-Ct method, which was normalized by loading control 36B4.
Reporter gene assays
Brown pre-adipocytes and C3H10T1/2 cells were transfected with PPARγ
transactivation reporters, which contain a fusion of murine PPARγ ligand binding
domain coupled to the Gal4 DNA binding domain (mPPARγ-Gal4), a reporter containing
an upstream activating sequence (UAS)-linked luciferase (4xUAS-thymidine kinase-luc),
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and β-galactosidase (β-gal) expression plasmid. PPARγ transactivation reporters were
a gift from Dr. Susanne Mandrup at University of Southern Denmark, Denmark. The
cells were then pre-treated with C12-iEDAP, LPS, Pam3CSK or the vehicle control for 2
h and then co-treated with or without PPARγ ligand rosiglitazone (Rosi, 0.5 μM/L) for 15
h. In some cases, the cells were pre-treated with NF-κB inhibitor CAPE or the vehicle
DMSO for 2 h before the PRR ligand was added, or the cells were infected with
adenovirus that encodes IκBα super-repressor (SR) or the control virus encodes β-gal
for 24 h before being transfected with PPARγ transactivation reporters. For NF-κB
activation experiments, C3H10T1/2 cells were infected with adenovirus encoding NFκB-Luc reporter gene for 24 h. The cells were then stimulated with C12-iEDAP, LPS,
Pam3CSK4, or the vehicle control for 15 h. The cell lysate was prepared and reporter
luciferase and β-gal activities were measured with GloMax Luminometer (Promega,
Madison, WI).
Oil red O staining and quantification
Differentiated brown adipocytes and C3H10T1/2 cells were fixed with 4%
formaldehyde solution overnight, and lipid accumulation were stained with oil red O
(ORO) and quantified by absorbance at 500 nm in a spectrophotometer.
Statistical analysis
All data were presented as means ± SE. Measurements were performed in
triplicates. Data were Log transformed when appropriate. Statistical analysis was
performed using SigmaPlot 12.0 (Systat Software, Inc.). One way ANOVA with repeated
measures followed by multiple comparisons test (Student-Newman-Keuls Method) were
performed to determine the differences between the treatment groups and/or time
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points. Student’s t-test was performed when appropriate. The level of significance was
set at P < 0.05.
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3.4 Results
mRNA expression and functionality of PRR during commitment and
differentiation of brown-like adipocyte of multipotent mesodermal stem
C3H10T1/2 cells
We examined mRNA expression of selected PRRs, NOD1, NOD2, TLR4 and
TLR2 in C3H10T1/2 cells after plating (D-5), commitment (D0), and differentiation (D6)
to brown-like adipocytes, as shown in Figure 9A. mRNA of all examined PRR was
significantly up-regulated during commitment and then down-regulated during the
differentiation phase (Figure 9A), leading to a higher mRNA expression for NOD1 and
TLR4 (p<0.05) and no changes of mRNA expression for NOD2 and TLR2 in brown-like
adipocytes (Figure 9A). Comparisons among the PRRs show that TLR4 mRNA
expression was the highest, followed by NOD1 and TLR2, and NOD2 mRNA expression
was the lowest after the cells were plated at D-5 (Figure 9B). Similar patterns were
maintained through commitment (D0) and differentiation (D6) (Figure 9B).
We examined the functionality of the selected PRRs by NF-κB activation assays.
Except for NOD2 ligand MDP (data not shown), the synthetic ligand of NOD1 (C12iEDAP), TLR4 (LPS), and TLR2 (Pam3CSK4) induced robust NF-κB activation in
C3H10T1/2 cells (p<0.001) (Figure 9C). Taken together, these results indicate that
selected PRRs are expressed and functional in C3H10T1/2 cells.
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Chronic activation of NOD1, TLR4, or TLR2 suppresses brown-like adipocyte
differentiation of C3H10T1/2 cells
We next examined the effects of chronic activation of NOD1, TLR4, or TLR2 on
brown-like adipocyte differentiation of C3H10T1/2 cells in the presence or absence of
their respective synthetic ligand, as shown in Figure 10A. More than 95% of C3H10T1/2
cells were differentiated into brown-like adipocytes at D6 after being committed by
BMP4 and differentiated as previously reported (Xue et al. 2014). The presence of the
synthetic ligand of NOD1, TLR4, or TLR2 during both the commitment and
differentiation phases significantly suppressed the differentiation of brown-like
adipocytes, as revealed by the paucity of oil red O stained multilocular, lipid-filled brown
adipocytes (Figure 10B), decreased lipid accumulation (Figure 10C), and almost
completely abolished protein expression of established brown adipocyte marker PPARγ,
PGC-1α, and UCP-1, compared with the controls (Figure 10D).
Analysis of mRNA further revealed that mRNA expression of PPARγ, PGC-1α,
and UCP-1 was consistent with the protein expression (Figure 11A). mRNA expression
of PR domain containing 16 (PRDM16), a zinc-finger binding protein recently identified
as an early regulator for brown cell fate (Seale et al. 2007), was also significantly
suppressed (p<0.01) (Figure 11A). In addition, of the two transcription factors regulating
mitochondrial gene expression, mRNA expression of nuclear respiratory factor 1 (Nrf-1)
(p<0.05 for NOD1 and TLR2, p<0.01 for TLR4), but not transcription factor A (Tfam),
was down-regulated by the PRR activation (Figure 11B). Consequently, mRNA
expression of the two nucleus-encoded mitochondrial genes, cytochrome b-c1 complex
subunit 6 (Uqcrh) (p<0.05) and cytochrome c oxidase subunit IV a (Cox4a) (p<0.01)
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were also down-regulated by the PRR activation (Figure 11B). Taken together, these
results suggest that PRR activation suppresses brown-like differentiation, including
mitochondrial biogenesis, of C3H10T1/2 cells.
Differential regulation of the novel brown and white adipocyte-specific markers
by chronic PRR activation in C3H10T1/2 cells
The transcriptome analysis (Timmons et al. 2007) and a global transcription
factor screen (Seale et al. 2007) have identified differences in the transcription factor
profiles between brown and white adipocytes. To examine whether PRR activation
could modulate brown versus white adipocyte fate, we examined the mRNA expression
of novel brown transcription factor zinc finger protein of the cerebellum 1 (Zic1), LIM
homeobox protein 8 (Lhx8), and mesenchyme homeobox 2 (Meox2), and white specific
marker insulin-like growth factor-binding protein 3 (IGFBP3) and homeo box C9 (Hoxc9)
at D6 in C3H10T1/2 cells. Activation of TLR4, but not NOD1 or TLR2, significantly
suppressed novel brown marker Zic1 mRNA expression (p<0.05) (Figure 11C). In
contrast, NOD1 activation significantly up-regulated mRNA expression of Lhx8 and
Meox-2 (p<0.01), which were not affected by the activation of TLR4 or TLR2 (Figure
11C). Moreover, activation of NOD1 and TLR4, but not TLR2, significantly up-regulated
mRNA expression of white specific IGFBP3 (p<0.05), whereas activation of NOD1,
TLR4, or TLR2 did not alter Hoxc9 mRNA expression at D6 in C3H10T1/2 cells (Figure
11D).
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PRR activation only during the commitment phase is sufficient to lead to
suppression of differentiation of brown-like adipocytes of C3H10T1/2 cells
The commitment of multipotent stem cells into either white or brown adipocytes
has been a focus of recent studies. The commitment of C3H10T1/2 cells into brown-like
adipocytes is positively regulated by bone morphogenic proteins (BMPs) (Tseng et al.
2008; Xue et al. 2014). We examined whether activation of NOD1, TLR4, or TLR2 only
during the commitment is sufficient enough to lead to suppression of differentiation of
brown-like adipocytes of C3H10T1/2. C3H10T1/2 cells were committed towards brownlike adipocytes with BMP4 in the presence or absence of the PRR synthetic ligand until
the cells reach confluency, followed by the induction to differentiation, as shown in
Figure 12A. Activation of NOD1, TLR4, or TLR2 only during the commitment was
sufficient to suppress differentiation of brown-like adipocytes of C3H10T1/2 cells,
although to a lesser degree, as revealed by paucity of the oil red O stained multilocular,
lipid-filled brown-like adipocytes (Figure 12B), decreased lipid accumulation (Figure
12C), and attenuated protein expression of PPARγ, PGC-1α, and UCP-1 at D6,
compared with the controls (Figure 12D).
Analysis of mRNA of established brown marker PPARγ, PGC-1α, and UCP-1
was consistent with the protein expression (Figure 13A). Notably, PRDM16 mRNA was
not suppressed at D6 when PRR activation only occurred during the commitment
(Figure 13A). Activation of NOD1, TLR4, or TLR2 during commitment suppressed
mRNA expression of Uqcrh (p<0.01) and Cox4a (p<0.05), whereas mRNA expression
of Tfam and Nrf-1 was not suppressed at D6 (Figure 13B). Moreover, only Zic-1 mRNA
expression was suppressed by TLR4 activation (p<0.05), and mRNA expression of
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Lhx8 or Meox-2 was not altered at D6 (Figure 13C). Further, activation of NOD1 or
TLR4, but not TLR2, during commitment induced IGFBP3 mRNA, whereas none of the
activation altered Hoxc9 mRNA at D6 in C3H10T1/2 cells (Figure 13D).
Activation of PRR suppresses the commitment to brown-like adipocytes of
C3H10T1/2 cells
To gain insights into the effects of PRR activation on commitment, we further
examined the changes in mRNA expression by PRR activation at the commitment.
C3H10T1/2 cells were committed towards brown-like adipocytes with BMP4 in the
presence or absence of the PRR synthetic ligand until the cells reach confluency (D0),
as shown in Figure 14A. Activation of NOD1, TLR4, or TLR2 significantly suppressed
mRNA expression of PGC-1α (p<0.01), but not PPARγ at the commitment (Figure 14B).
Surprisingly, activation of NOD1 and TLR4, but not TLR2, significantly induced upregulation of PRDM16 (p<0.05) (Figure 14B). No significant change was noted for Tfam,
Nrf-1, Uqcrh, and Cox4a at the commitment (data not shown). Moreover, activation of
NOD1, TLR4, or TLR2 significantly suppressed mRNA expression of Zic1, Lhx8, and
Meox-2 and white specific marker Hoxc9 (Figure 14C). In contrast, no changes of
IGFBP3 mRNA were noted by the activation of NOD1 and TLR4, but it was induced by
TLR2 activation (p<0.05) (Figure 14D).
Chronic activation of NOD1, TLR4, or TLR2 suppresses terminal differentiation of
immortalized brown pre-adipocytes derived from BAT of mice
To validate the effects of chronic PRR activation on multipotent stem cells, we
further examined the effects of PRR activation on terminal brown differentiation from
immortalized brown pre-adipocytes derived from classical BAT of C57BL6 mice. We
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have previously shown that NOD1, TLR4, and TLR2 were expressed and functional in
these cells (Bae et al. 2014). Brown pre-adipocytes were differentiated in the presence
or absence of the synthetic ligand during the differentiation, as shown in Figure 15A.
Activation of NOD1, TLR4, or TLR2 suppressed brown adipocyte differentiation
compared to the control, as revealed by the paucity of oil red O stained multilocular,
lipid-filled brown adipocytes (Figure 15B), reduced lipid accumulation (Figure 15C), and
attenuated protein expression of brown-specific marker PPARγ, PGC-1α, and UCP-1
(Figure 15D) at D6. Analysis of mRNA showed that activation of NOD1, TLR4, or TLR2
also suppressed mRNA expression of PPARγ, PGC-1α, PRDM16, and UCP-1 (p<0.01)
(Figure 15E). Moreover, mRNA expression of nucleus-encoded mitochondrial gene
Uqcrh and Cox4a was suppressed by the examined PRR (p<0.01); however, only TLR4
activation significantly suppressed mRNA expression of Tfam and Nrf-1 at D6 (p<0.01)
(Figure 15F).
Activation of PRR suppresses PPARγ transactivation through NF-κB pathway
To explore molecular mechanisms by which activation of NOD1, TLR4, or TLR2
suppressed brown adipocyte differentiation, we examined whether activation of NOD1,
TLR4, or TLR2 affects PPARγ transactivation, the key event for brown adipocyte
differentiation, using PPARγ transactivation reporters. Activation of NOD1, TLR4, or
TLR2 suppressed PPARγ ligand rosiglitazone (Rosi)-induced PPARγ transactivation in
C3H10T1/2 cells, which was reversed by the specific NF-κB inhibitor CAPE (Figure
16A), and IκB super-repressor (IκB(SR)) (Figure 16B), which contains two amino acid
substitutions (S32A/S36A) that prevent phosphorylation and degradation of the protein
and blocks the activation of NF-κB in response to proinflammatory stimulations (Jobin et
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al. 1998). Similarly, activation of NOD1, TLR4, or TLR2 also suppressed Rosi-induced
PPARγ transactivation in brown pre-adipocytes, which was reversed by NF-κB inhibitor
CAPE (Figure 16D) and IκB(SR) (Figure 16E). Consistently, suppression of brown-like
adipocyte differentiation of C3H10T1/2 cells by PRR activation during the commitment
was reversed by NF-κB inhibitor CAPE, compared to the vehicle control, as revealed by
attenuation of the suppression of lipid accumulation (Figure 16C).
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3.5 Discussion
PRR-mediated inflammation has been implicated in adipose inflammation and
obesity. In current studies, we demonstrate, for the first time, that chronic activation of
selected PRR leads to suppression of brown adipogenesis of multipotent stem cells and
committed brown pre-adipocytes, suggesting that PRR activation negatively impacts
BAT development. Our results have revealed a new role of PRR-mediated inflammation
in the development of obesity.
The C3H10T1/2 line is the best characterized mesodermal multipotent stem cell
line that faithfully mimic multipotent stem cells in vivo and can be induced to undergo
commitment and differentiation to the muscle, bone, cartilage, and adipose lineage
(Taylor and Jones 1979; Konieczny and Emerson 1984; Gregoire et al. 1998; Shin et al.
2000; Mikami et al. 2011; Tang and Lane 2012). The genetic mapping studies have
revealed that brown adipocytes and muscle, but not white adipocytes, were derived
from Myf-5 expressing precursor cells (Seale et al. 2008). The transcription factor
PRDM16 was shown to act as a switch to drive differentiation of the Myf-5 expressing
stem cells into brown adipocytes. Knockdown of PRDM16 in the precursor cells resulted
in loss of brown fat characteristics, leading to muscle cell phenotype, while overexpression of PRDM16 in white pre-adipocytes or myoblasts resulted in brown
adipocyte phenotype (Seale et al. 2008).
It has been reported that BMPs, members of transforming growth factor-β (TGFβ)
superfamily, play critical roles in the commitment and differentiation of brown-like
adipocytes from C3H10T1/2 cells. It has been demonstrated that pre-treatment of BMP4
at 20 ng/ml during proliferation produced clonal lines that were capable of differentiating
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into brown-like adipocytes when subjected to brown differentiation inducers without
exogenous BMP4 and into brown-like fat when implanted into athymic nude mice (Xue
et al. 2014). BMP4 pre-treatment was shown to induce up-regulation of PRDM16,
leading to the commitment of C3H10T1/2 cells into brown preadipocytes (Xue et al.
2014).
Effects of PRR activation on commitment and differentiation
We have used C3H10T1/2 line to gain insights into the effects of chronic PRR
activation on commitment and differentiation of brown-like adipocytes from mesodermal
stem cells. Our results demonstrate that chronic activation of selected PRR during both
the commitment and differentiation suppressed the brown-like adipogenesis of
C3H10T1/2 cells, as revealed by paucity of oil red O stained, multilocular brown
adipocyte morphology and suppressed gene expression of brown specific markers, and
lipid accumulation. It should be noted that, although to a lesser degree, compared to
that of PRR activation in both the commitment and differentiation phase, PRR activation
only during the commitment phase was sufficient enough to suppress brown-like
differentiation of C3H10T1/2 cells. Gene expression analysis revealed that PRR
activation during commitment suppressed mRNA expression of PGC-1α, but not PPARγ
or PRDM16, at the commitment. In fact, there was no change of PPARγ mRNA,
whereas PRDM16 mRNA was significantly up-regulated by activation of NOD1 and
TLR4, but not TLR2. PPARγ, PGC-1α, and PRDM16 are considered to be the core
regulators for brown differentiation (Richard and Picard 2011; Satterfield and Wu 2011;
Harms and Seale 2013). Studies have shown that PRDM16 acts primarily through
binding to and modulating the activities of other transcription factors, including
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CCAAT/enhancer binding protein beta (C/EBPβ) (Kajimura et al. 2008), PPARγ (Seale
et al. 2008), and PGC-1α (Seale et al. 2007). PPARγ is the transcription factor that not
only regulates white adipocyte differentiation, but also brown adipocyte differentiation
(Rosen et al. 1999; Imai et al. 2004). PGC-1α is a co-activator for PPARγ. Activation of
PPARγ and PGC-1α subsequently up-regulate a number of genes involved in brown
adipocyte differentiation and function, including UCP-1 (Richard and Picard 2011;
Harms and Seale 2013). In addition, PGC-1α has been shown to control mitochondrial
biogenesis through induction of uncoupling proteins and regulation of nuclear
respiratory factors (Wu et al. 1999). Our results demonstrate that PRR activation during
the commitment leads to suppression of brown-like differentiation, characterized by
suppressed mRNA expression of established brown marker PPARγ, PGC-1α, and UCP1, but not PRDM16, possibly through modulation of early events in the commitment,
such as more upstream transcription factors, and epigenetic changes, which directly or
indirectly suppressed the core regulators, leading to the suppression of brown-like
differentiation. Further PRR activation during the differentiation leads to more robust
suppression of differentiation, characterized by suppression of almost all brown specific
markers, including PRDM16.
Effects of PRR activation on novel brown and white specific markers: To whiten it
or not?
To our knowledge, this is the first report of PRR activation on novel brown versus
white specific markers in brown-like differentiation of C3H10T1/2 cells. Identification of
novel brown and white specific markers has provided molecular insights into the
characterization of brown, white, and beige adipocytes. It has been reported that
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chronic treatment with the PPARγ agonist rosiglitazone induced browning of
epididymally derived white adipocyte cultures with norepinephrine-inducible UCP-1
gene expression and thermogenic capacity. These cells were characterized with low
mRNA expression of Zic-1, Lhx8, and Meox2, novel transcription factors now
associated with classic brown adipocytes (Timmons et al. 2007), decreased white
adipocyte specific IGFBP3, but retained white specific Hoxc9 expression (Petrovic et al.
2008). We show that selected PRR activation during both commitment and
differentiation differentially modulated novel brown specific markers. TLR4 activation
suppressed Zic1 mRNA, which was not affected by the activation of NOD1 or TLR2,
whereas NOD1 activation significantly induced mRNA of Lhx8 and Meox2, which were
not affected by activation of TLR4 or TLR2. In contrast, activation of NOD1 and TLR4,
but not TLR2, significantly induced white specific IGFBP3 mRNA and no significant
changes in Hoxc9 were observed. Only the suppression of Zic1 by TLR4 activation and
induction of IGFBP3 by NOD1 and TLR4 remained when the PRR activation only
occurred in the commitment phase. Together, our results suggest that activation of PRR
differentially modulate brown versus white marker gene expression in the stem cell
differentiation. It remains to be determined whether activation of certain PRR, TLR4 in
particular, induces “whitening” in brown-like adipocytes differentiated from C3H10T1/2.
Further characterization of the role of each of these novel brown and white specific
marker genes in controlling brown versus white cell fate will provide new insights into
the impact of PRR activation on these processes.
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Mechanisms of chronic PRR activation on brown differentiation
It has been shown that activation of NOD1 (Purohit et al. 2012) or TLR4 (Song et
al. 2006) suppressed 3T3-L1 white adipocyte differentiation. Activation of NOD1
induced NF-κB activation in 3T3-L1 cells, which correlated with the suppression of
ligand-induced PPARγ activation (Purohit et al. 2012). It has been demonstrated that
NOD1, TLR4, and TLR2 are expressed and functional in brown adipocytes (Bae et al.
2014). Here, we show that these PRRs are expressed and functional in C3H10T1/2
cells. Moreover, we show that activation of NOD1, TLR4, or TLR2 suppressed PPARγ
transactivation, which was reversed by the pharmacological inhibitor of NF-κB (CAPE)
and IκBα super-repressor (IκB (SR)) in both cell types. Further, we show NF-κB
inhibition by CAPE attenuated suppression of brown-like differentiation by PRR
activation, indicated by the oil red O stained lipid accumulation. Together, the results
suggest that suppression of brown adipogenesis by PRR activation is at least in part
mediated through suppression of PPARγ transactivation by NF-κB pathway.
In conclusion, we have demonstrated the suppressive effects of chronic
activation of selected PRR on brown adipogenesis of multipotent mesodermal stem
C3H10T1/2 cells and immortalized brown preadipocytes. Our results suggest that
suppression of brown differentiation could, at least in part, be mediated by suppression
of PPARγ transactivation via NF-κB pathway, and anti-inflammatory therapies targeting
PRRs could be beneficial for BAT development.
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Figure 9 Selected PRRs are expressed and functional during commitment and
differentiation of multipotent mesodermal stem C3H10T1/2 cells
C3H10T1/2 cells were committed with BMP4 for 5 days until confluency, and then were
differentiated into brown-like adipocytes for another 6 days, as shown in the diagram.
Total RNA were collected at after plating (D-5), commitment (D0), and differentiation
(D6) according to the diagram. (A, B) mRNA expression of PRRs were evaluated by
semi-quantitative RT-PCR (A), and relative mRNA expression of PRRs at D-5, D0, and
D6 were compared (B). The relative mRNA expression was normalized to 36B4 and
expressed as fold of NOD2 value or D-5 value (set as 1). (C) Functionality of the
selected PRRs was measured by NF-κB reporter assays. Data are mean±SE (n=3).
Different letters indicate significant differences between bars. , significantly different
from the controls with p<0.01.
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Figure 10 Chronic activation of NOD1, TLR4, or TLR2 suppresses brown-like
adipocyte differentiation of C3H10T1/2 cells
C3H10T1/2 cells were committed and differentiated into brown-like adipocytes the
presence of C12-iEDAP (10 µg/ml), LPS (1 µg/ml), Pam3CSK4 (10 µg/ml), or the
vehicle control, as shown in (A). ORO stained cell morphology (B) and ORO
absorbance (C) are shown. (D) Protein expression of established brown specific marker
PPARγ, PGC-1α, and UCP-1 at D6 were analyzed by western blot. ERK1/2 is shown as
a loading control. Data are mean±SE (n=3). **, significantly different from the controls
with p<0.01.
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Figure 11 Molecular insights into the mechanisms by which chronic PRR
activation suppresses brown-like differentiation of C3H10T1/2
C3H10T1/2 cells were committed and differentiated into brown-like adipocytes in the
presence of C12-iEDAP (10 µg/ml), LPS (1 µg/ml), Pam3CSK4 (10 µg/ml), or the
vehicle control. mRNA expression of established brown markers PPARγ, PGC-1α,
PRDM16, and UCP-1 (A); mitochondrial transcription factors, Tfam and Nrf-1, and
structural genes, Uqcrh and Cox4a (B); novel brown transcription factors, Zic-1, Lhx8,
and Meox-2 (C); and white specific markers IGFBP3 and Hoxc9 (D) at D6 are shown.
The relative gene expression was normalized to 36B4 gene. Data are mean±SE (n=3).
*, **, significantly different from the controls with p<0.05 and p<0.01, respectively.
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Figure 12 PRR activation only during the commitment phase is sufficient to lead
to suppression of brown-like differentiation of C3H10T1/2 cells
C3H10T1/2 cells were committed with BMP4 in the presence of C12-iEDAP (10 µg/ml),
LPS (1 µg/ml), Pam3CSK4 (10 µg/ml), or the vehicle control and then differentiated into
brown-like adipocytes without PRR ligands until D6, as shown in (A). ORO stained cell
morphology (B) and ORO absorbance (C) were measured. (D) Protein expression of
established brown specific marker PPARγ, PGC-1α, and UCP-1 at D6 were analyzed by
western blot. ERK1/2 is shown as a loading control. Data are mean±SE (n=3). **,
significantly different from the controls with p<0.01.
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Figure 13 Molecular insights into the mechanisms by which PRR activation only
during the commitment suppresses brown-like differentiation of C3H10T1/2 cells
C3H10T1/2 cells were committed with BMP4 in the presence of C12-iEDAP (10 µg/ml),
LPS (1 µg/ml), Pam3CSK4 (10 µg/ml), or the vehicle control and then differentiated into
brown-like adipocytes without PRR ligands until D6. mRNA expression of established
brown markers (A); mitochondrial biogenesis markers (B); novel brown markers (C);
and white specific markers (D) at D6 are shown. The relative mRNA expression was
normalized to 36B4 and expressed as fold of the control (set as 1). Data are mean±SE
(n=3). *, **, significantly different from the controls with p<0.05 and p<0.01, respectively.
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Figure 14 PRR activation suppresses the commitment to brown-like adipocytes of
C3H10T1/2 cells
C3H10T1/2 cells were committed towards brown-like adipocytes with BMP4 in the
presence of the C12-iEDAP (10 µg/mL), LPS (1 µg/mL), Pam3CSK4 (10 µg/mL), or the
vehicle control until the cells reach confluency, as shown in (A). mRNA expression of
established brown markers (B), novel brown markers (C), and white specific markers
(D) at D0 are shown. The relative mRNA expression was normalized to 36B4 and
expressed as fold of the control (set as 1). Data are mean±SE (n=3). *, **, significantly
different from the controls with p<0.05 and p<0.01, respectively.
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Figure 15 Chronic activation of NOD1, TLR4, or TLR2 suppresses terminal
differentiation of immortalized brown preadipocytes derived from BAT of mice
Brown pre-adipocytes were differentiated in the presence of C12-iEDAP (10 µg/mL),
LPS (1 µg/mL), Pam3CSK4 (10 µg/mL), or the vehicle control, as shown in (A). ORO
stained cell morphology (B) and ORO absorbance (C) were measured. (D) Protein
expression of established brown markers was analyzed by western blot. ERK1/2 is
shown as a loading control. (E, F) mRNA expression of brown specific markers (E) and
mitochondrial biogenesis markers (F) were analyzed at D6. The relative mRNA
expression was normalized to 36B4 and expressed as fold of the control (set as 1).
Data are mean±SE (n=3). **, significantly different from the controls with p<0.01.
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Figure 16 Activation of PRR suppresses PPARγ transactivation through NF-κB
pathway
(A, B, D, E) PPARγ transactivation reporters were transfected into C3H10T1/2 (A, B)
and brown pre-adipocytes (D, E). The cells were pretreated with NF-κB inhibitor CAPE
or DMSO (A, D) or infected with adenovirus that encodes IκB supper-repressor IκB(SR)
or the control virus (B, E) before the addition of selected PRR ligands and PPARγ
synthetic ligand rosiglitazone (Rosi, 0.5 µM) together with the inhibitor or DMSO in A
and D for 15 h. Cell lysate was prepared and reporter assays were performed. PPARγ
transactivation normalized by the luciferase activities is presented as fold of that of the
controls (set as 1). (C) C3H10T1/2 cells were committed with BMP4 in the presence of
the PRR ligand and NF-κB inhibitor CAPE or DMSO during the commitment and then
differentiated into brown-like adipocytes without PRR ligand and the inhibitor until D6,
as shown in the diagram. ORO absorbance was measured. Data are mean±SE (n=3).
**, significantly different from the controls with p<0.01.
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CHAPTER IV
NARINGENIN, A CITRUS FLAVANONE, ENHANCES ISOPROTERENOL
STIMULATED THERMOGENIC ACTIVATION OF 3T3-L1 ADIPOCYTES
VIA PKA/P38 PATHWAYS
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A version of this chapter will be submitted by Jiyoung Bae, Jiangang Chen, Ling
Zhao entitled “Naringenin, a citrus flavanone, enhances isoproterenol stimulated
thermogenic activation of 3T3-L1 adipocytes via PKA/p38 pathways”
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4.1 Abstract
Promoting thermogenesis through increasing the activities of functional brown
adipose tissues (BAT) has promised new hope for obesity treatment and prevention.
Naringenin is an abundant flavanone mainly found in citrus fruits. Emerging evidence
suggests that naringenin has anti-inflammatory and anti-oxidant properties and is
beneficial in obesity and obesity related chronic diseases. Recently, naringenin has
been reported to be capable of activating nuclear receptors, including PPAR gamma;
however, it is not clear whether naringenin promotes activities of functional BAT, similar
to what has been reported for rosiglitazone, a synthetic ligand for PPAR gamma. Here,
we investigated the effects of naringenin on browning and isoproterenol-stimulated
thermogenic activation of 3T3-L1 adipocytes. 3T3-L1 cells were differentiated into
mature adipocytes with standard differentiation cocktail in the presence or absence of
naringenin, followed by stimulation with β-adrenergic agonist isoproterenol. Although
naringenin did not increase UCP-1 mRNA at basal condition, it significantly increased
the isoproterenol-stimulated upregulation of UCP-1 and PGC-1α mRNA expression and
enhanced isoproterenol-stimulated thermogenesis. Moreover, naringenin enhanced
activation of PKA and phosphorylation of p38 MAPK downstream of isoproterenol
stimulation; and inhibition of either PKA or p38 by their respective pharmacological
inhibitors blocked naringenin-induced upregulation of UCP-1 mRNA. Taken together,
our results demonstrate that naringenin enhances isoproterenol-induced thermogenic
activation of 3T3-L1 adipocytes via PKA/p38 pathways.
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4.2 Introduction
Obesity has been a growing problem across the globe over the past few
decades, and if untreated, leads to metabolic disorders. Two types of adipose tissues,
white adipose tissue (WAT) and brown adipose tissue (BAT), contribute to energy
storage and expenditure. Results from recent animal and human studies, however,
have identified inducible brown-like adipocytes, also known as beige adipocytes, in
WAT (Giralt & Villarroya, 2013; Lo & Sun, 2013; A. Park, Kim, & Bae, 2014; J. W. Park
et al., 2015; Rosenwald & Wolfrum, 2014). When exposed to cold temperature,
hormonal stimuli (e.g. irisin and T3) (Obregon, 2014a; Zhang et al., 2014), or
pharmacological treatment (e.g. rosiglitazone, bone morphogenetic protein, and
isoproterenol) (Elsen et al., 2014; Obregon, 2014b; J. Wu et al., 2012), beige adipocytes
can adopt a brown adipocyte phenotype via browning with increased UCP-1 expression,
contributing to thermogenesis and energy expenditure.
Naringenin (4’,5,7-trihydroxyflavanone), a citrus flavanone found in grapefruit,
has emerged as a dietary bioactive compound with myriads of beneficial effects (Alam
et al., 2014; Assini et al., 2013; Coelho, Hermsdorff, & Bressan, 2013; E Orhan et al.,
2015; Mir & Tiku, 2015; Sharma et al., 2015). For example, several studies have
reported anti-inflammatory properties of naringenin in various cell/disease models
(Chtourou et al., 2015; H. Y. Park, Kim, & Choi, 2012; Seyedrezazadeh et al., 2015; Shi
et al., 2009; L.-H. Wu et al., 2015; Yu, Ma, Yue, Yao, & Mao, 2015).
It has been reported that oral administration of naringenin in rodents decrease
WAT adipose mass (Assini et al., 2013; Ke et al., 2015), reduce adipose tissue
inflammation (Ke et al., 2015; Hiroki Yoshida et al., 2014; H. Yoshida et al., 2013) and
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macrophage infiltration (Hiroki Yoshida et al., 2014) in high-fat induced obesity.
Naringenin suppressed Toll-like receptor 2 (TLR2) expression induced by TNFα and
high fat feeding (H. Yoshida et al., 2013). Recently, naringenin has been reported to
activate nuclear receptors, including PPARγ (Goldwasser et al., 2010). PPARγ agonist
rosiglitazone induced “browning” in primary culture derived from subcutaneous white fat
(Petrovic et al., 2010) and induced UCP-1 expression and thermogenesis (Petrovic,
Shabalina, Timmons, Cannon, & Nedergaard, 2008). However, it is not clear whether
naringenin has such effects.
In this report, we investigated the impact of naringenin treatment on browning
and thermogenic activation by isoproterenol, a β-adrenergic receptor agonist, in 3T3-L1
adipocytes. We report naringenin at 10 μM significantly promoted the isoproterenolstimulated upregulation of UCP-1 and PGC-1α mRNA expression and thermogenesis in
the 3T3-L1 adipocytes. We further demonstrated the effects by naringenin are mediated
through the activation of PKA/p38 MAPK signaling pathways.
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4.3 Materials and Methods
Reagents
Murine 3T3-L1 cells were obtained from ATCC (Manassas, VA). Naringenin,
Dulbecco’s modified Eagle’s medium (DMEM), 3-Isobutyl-L-methylxanthine,
dexamethasone, insulin, isoproterenol (ISO), and rosiglitazone (Rosi) were from Sigma
(St. Louis, MO). Calf serum (CS) was purchased from Hyclone (Logan, UT) and fetal
bovine serum (FBS) was purchased from Atlas Biologicals (Fort Collins, CO). The
pharmacological inhibitors for p38 (SB203580) and PKA (H-89) were from Tocris
Bioscience (Ellisville, MI). Anti-phospho-p38 (Thr180/Tyr182) (no. 9211), anti-p38 (no.
9212) antibodies, and horseradish peroxidase-conjugated goat anti-rabbit were from
Cell Signaling Technology (Danvers, MA).
Naringenin was dissolved in dimethyl sulfoxide (DMSO, Sigma, St. Louis, MO) to
make 50 mM concentration followed by dilution in DMSO to make 0, 5 and 10 mM for
treatment. The final DMSO concentration in cell culture medium was ≤ 0.1%.
Cell culture and treatment
Murine 3T3-L1 cells were grown in DMEM supplemented with 10% CS at 37°C
humidified atmosphere of 5% CO2 in air until they reached confluence [designated as
day 0 (D0)]. The cells were differentiated in DMEM containing 10% FBS, 1 μM/L
dexamethasone, 0.5 mM/L 3-isobutyl-1-methylxanthine (IBMX) and 10 μg/mL insulin
(Cohen et al.) for 3 days, followed by treatment with 10 μg/mL insulin in DMEM
containing 10% FBS for an additional 2 days. The cells were then maintained in DMEM
containing 10% FBS until fully differentiated at day 7 (D7).
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To examine the effects of naringenin on browning of 3T3-L1 adipocytes,
confluent 3T3-L1 cells were differentiated with DMI in the presence or absence of
various doses of naringenin starting on D0 as indicated in the figure legends. Fresh
naringenin was replaced at each change of the media during the entire differentiation
process. Rosi (1 μM) was used as a positive control. On D7, the cells were stimulated
with Isoproterenol (ISO, 1 µM) or the vehicle control for 6 h. Pharmacological inhibitors,
SB203580 and H-89, were applied one hour before the ISO stimulation as indicated in
the figure legends.
PKA activity
On D7, 3T3-L1 adipocytes differentiated in the presence or absence of
naringenin (10 µM), or Rosi (1 µM) were serum starved in 0.25% FBS containing DMEM
for 1 h. The cells were stimulated with or without ISO (1 μM) for further 6 h. PKA
activities were measured from total cell lysates using DetectX PKA activity kit (Arbor
Assays, Ann Arbor, MI) according to the manufacturer’s instructions.
Western blot analysis
Total cell lysates were prepared using 1X lysis buffer (Cell Signaling, Danvers,
MA) and protein concentration were determined by the BCA assay kit (Thermo
Scientific, Waltham, MA). Twenty micrograms of total cell lysates were subjected to
10% SDS-PAGE and transferred to polyvinylidene difluoride membrane (Bio-Rad,
Hercules, CA). The membrane was blocked in 20 mM Tris·HCl, 137 mM NaCl, and
0.1% Tween 20 (pH 7.4) containing 5% nonfat milk. The membrane was immunoblotted
with primary antibodies at 4°C overnight followed by secondary antibody conjugated
with horseradish peroxidase for 1 h. The membrane was exposed on X-ray film after
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developed by ECL Western blot detection reagents (GE Healthcare, Piscataway, NJ).
The membranes was stripped in stripping buffer (62.5 mM Tris-HCl, 2 % SDS, and 100
mM 2-mercaptoethanol) at 50 °C for 10 min.
RNA preparation and quantitative real-time PCR analysis
Total RNA was prepared using TRI reagent (Molecular Research Center,
Cincinnati, OH) according to the manufacturer’s instructions. Total RNA abundance was
quantified using NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies,
Wilmington, DE). Reverse transcription was carried out using High capacity cDNA
Reverse Transcription kit (Thermo Scientific, Pittsburgh, PA) according to the
manufacturer’s instructions. mRNA expression of target genes and the housekeeping
gene 36B4 was measured quantitatively using Absolute Blue QPCR SYBR Green ROX
mix (Thermo Fisher Scientific, location). PCR reactions were run in a 96-well format
using an ABI 7300HT instrument. Cycle conditions were 50°C 2 min, 95°C 15 min and
then 40 cycles of 95°C for 15 s/60°C for 1 min. Relative gene expression was calculated
using the 2-ΔΔCt method (Dawson et al., 2012), which normalizes against a house
keeping gene 36B4.
Reporter gene assays
3T3-L1 preadipocytes were seeded in 24-well plates were transiently transfected
with PPAR response element-driven luciferase reporter (PPRE-Luc) (PPRE-Luc was a
gift from Bruce Spiegelman (Addgene plasmid # 1015) or murine PPARγ ligand binding
domain (LBD) coupled to the Gal4 DNA binding domain (DBD) (mPPARγ-Gal4) and a
reporter construct containing an upstream activating sequence linked luciferase,
4xUAS-TK-luc (TK: thymidine kinase) (gifts from Dr Susanne Mandrup at University of
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Southern Denmark, Denmark) (Taxvig et al., 2012) with Fugene HD transfection
reagent (Promega, Madison, WI). The cells were then treated with naringenin or the
vehicle control DMSO for 18 h. Reporter luciferase activities were measured from cell
lysates with GloMax Luminometer (Promega, Madison, WI). Relative luciferase activities
were normalized by total protein concentrations measured by BCA assay kit.
Cellular bioenergetics measurements
3T3-L1 preadipocytes were differentiated in the presence or absence of
naringenin, or Rosi for 7 days. Then adipocytes were replated and seeded in 24-well XF
assay plates in DMEM containing 10% FBS for overnight followed by treated with ISO
(1 μM) for 6 h. After treatment, cells were rinsed with XF assay buffer (DMEM without
NaHCO3, 10 mM glucose, 2 mM pyruvate, and 2 mM GlutaMAX, pH 7.4) 3 times. A 500
μl of XF assay buffer was then added into each well, and equilibrated at non-CO2
incubator at 37°C for 1 h. Real-time measurements of oxygen consumption rate (OCR)
was conducted using XF24 Extracellular Flux Analyzer (Seahorse Biosciences, North
Billerica, MA). For the mitochondria stress test, mitochondrial complex inhibitors were
injected to sequentially in the following order: oligomycin (1 μM), carbonyl cyanideptrifluoromethoxyphenylhydrazone (FCCP; 0.75 μM), antimycin A/rotenone (1 μM
each), and 3 readings were taken after each injection. OCR was automatically recorded
by XF24 software v1.8 provided by the manufacturer.
Calculations of proton leak, coupling efficiency, maximal respiration, and ATP
production were performed according to the manufacturer’s instructions.
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Statistical analysis
All data are presented as mean±SE. Measurements were performed in
triplicates. Statistical analysis was performed using SigmaPlot 13.0 (Systat Software).
One-way ANOVA with repeated measures followed by multiple comparisons test
(Student-Newman-Keuls method) was performed to determine the differences of group
mean between the treatment groups and/or time points. Student’s t-tests were
performed when appropriate. The level of significance was set at P<0.05.
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4.4 Results
Naringenin dose-dependently enhances UCP-1 and PGC-1α mRNA in ISOstimulated 3T3-L1 adipocytes.
To investigate the browning effect of naringenin on white adipocytes, 3T3-L1
cells were differentiated in the presence or absence of naringenin (5, 10 μM). Rosi was
included as a positive control in the studies. At basal (e.g., non-stimulated) condition,
Rosi induced mRNA expression of established brown specific markers UCP-1, PGC-1α,
and induced novel brown marker PRDM16, and suppressed Meox-2, as reported
(Petrovic et al., 2010). Also, Rosi suppressed white specific marker IGFBP3, as
reported (Petrovic et al., 2010). In contrast, naringenin did not increase UCP-1 and
PGC-1α mRNA even when used up to 20 µM at the basal condition (data not shown);
however, at 10 µM, naringenin significantly increased mRNA expression of PRDM16
and suppressed Meox-2 and IGFBP3 mRNA (Figure 17A).
When stimulated with isoproterenol (ISO), naringenin at 10 μM, significantly
promoted ISO-induced UCP-1 activation, as demonstrated by the enhanced mRNA
expression of brown adipocyte specific genes, UCP-1 and PGC-1α (Figure 17B).
Naringenin enhances thermogenesis in ISO-stimulated 3T3-L1 adipocytes.
To determine whether the upregulation of UCP-1 mRNA by naringenin leads to
increase in mitochondrial uncoupling and thermogenesis, we examined oxygen
consumption rates coupled with mitochondrial stress tests in ISO-stimulated 3T3-L1
adipocytes which have been differentiated in the presence or absence of naringenin by
cellular bioenergetics measurements using XF24 Extracellular Flux Analyzers (Figure
18A-D). Naringenin at 10 μM significantly increased isoproterenol-stimulated oxygen
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consumption from proton leak (Figure 18A) and decreased coupling efficiency (Figure
18B); however, naringenin did not affect the ISO-stimulated maximal respiration (Figure
18C) and oxygen consumption from ATP production (Figure 18D).
Naringenin enhances isoproterenol-stimulated PKA activation and
phosphorylation of p38 MAPK.
Beta-adrenergic activation induces increase in cAMP levels, leading to PKA
activation and downstream p38 MAPK phosphorylation. ISO stimulation resulted in ~3
folds of PKA activities, compared to non-stimulated controls in mature 3T3-L1
adipocytes (Figure 19). Both Rosi and naringenin induced significant enhancement of
PKA activation induced by ISO (Figure 19).
We next examined whether naringenin treatment during 3T3-L1 adipocytes
differentiation affects p38 MAPK phosphorylation downstream of ISO stimulation.
Western analysis showed that ISO induced a peak of p38 phosphorylation at 15 min
upon the stimulation (Figure 20). In contrast, p38 phosphorylation was higher at the
basal state (time 0), and was significantly enhanced in naringenin treated 3T3-L1
adipocytes stimulated by ISO. Rosi induced the highest p38 MAPK phosphorylation at
the basal state and throughout the 60 min in 3T3-L1 adipocytes (Figure 20).
Naringenin activates PPRE reporter gene and transactivates PPARγ in 3T3-L1
cells.
To understand whether naringenin’s effects were mediated through PPARγ, we
performed reporter gene assays. Naringenin at 10 µM activated PPRE-Luc reporter up
to ~2 fold whereas Rosi induced ~3.5 fold compared to the controls in 3T3-L1 (Figure
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21A). In addition, naringenin at the same concentration transactivated PPARγ in 3T3-L1
cells (Figure 21B), consistent with the report (Goldwasser et al., 2010).
Enhancement of UCP-1 mRNA by naringenin is attenuated by inhibition of either
PKA or p38 MAPK.
To investigate whether the activation of PKA/p38 MAPK underlies ISO-stimulated
UCP-1 activation by naringenin, we employed the pharmacological inhibitors of PKA
H89 and p38 MAPK SB203580. The PKA inhibitor H89 blocked UCP-1 mRNA
expression at the basal state and the upregulation induced by naringenin and Rosi. The
p38 MAPK inhibitor SB203580 also significantly blocked basal as well as naringenin
and rosi-induced UCP-1 mRNA expression, although to a less extend (Figure 22).
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4.5 Discussion
Increasing functional brown adipose activities has become novel targets for
obesity treatment and prevention. Naringenin, a citrus flavanone, has been reported to
be beneficial in obesity and obesity associated chronic diseases. Here, we report that
naringenin dose-dependently enhances ISO-stimulated UCP-1 mRNA. Naringenin at 10
µM significantly increased ISO-induced uncoupled respiration from proton leak, but
decreased coupled efficiency, consistent with the enhancement on UCP-1 activation in
ISO-stimulated 3T3-L1 adipocytes by naringenin. Furthermore, naringenin enhanced
PKA activation and phosphorylation of p38 MARK downstream of ISO. Inhibition of
either PKA or p38 MARK blocked naringenin’s enhancement of ISO-stimulated UCP-1
activation. Our studies suggest that naringenin promotes ISO-stimulated thermogenic
activation of 3T3-L1 adipocytes via PKA/p38 MARK pathways (Figure 23).
3T3-L1 cell model, representing a very “white” cell model (Jun Wu & Spiegelman,
2014), has been used for identifying strategies to induce browning, i.e., acquiring of
brown-like adipocyte characteristics. Recent studies have suggested that 3T3-L1 cells
have the ability to induce UCP-1 and markers of beige adipocytes under specific
environmental conditions. β-adrenergic activation by isoproterenol, a nonspecific βadrenergic agonist, induces thermogenic activation in brown adipocytes and brown
adipose tissue. It has been reported that 3T3-L1 adipocytes differentiated from standard
differentiation protocol has significant increase of UCP-1 expression in response to ISO
(Asano et al., 2014). ISO induced a much higher UCP-1 expression in 3T3-L1
adipocytes treated with T3, Rosi and IBMX (Asano et al., 2014). Moreover, ISO at 100
µM also enhanced UCP-1 expression, leading to increased oxygen consumption rate in
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3T3-L1 adipocytes differentiated from standard differentiation protocol supplemented
with only T3 (Miller et al., 2015). To our knowledge, our finding is the first to report a
dietary bioactive compound naringenin at 10 µM enhances ISO-stimulated thermogenic
activation in 3T3-L1 adipocytes.
It is generally believed that the most critical test for functional brown adipocytes
is the ability to display induced thermogenesis by adrenergic activation (Petrovic et al.,
2010). The findings that naringenin did not induce UCP-1 expression at the basal state,
but enhanced UCP-1 activation and thermogenesis in response to ISO suggest that
naringenin promotes the development of functional brown adipocytes. The effect of
naringenin is in contrast with some of the reported “browning” agents, such as PPARγ
agonist Rosi, and Irisin. Rosi induced UCP-1 expression not only at the basal state but
also ISO-stimulated condition in primary adipocytes differentiated from stromal vascular
fraction of white fat (Petrovic et al., 2010). In our studies, we have included Rosi as a
positive control. We show that Rosi induced UCP-1 mRNA at both basal and ISOstimulated condition in 3T3-L1 adipocytes. Recombinant form of Irisin, a newly identifies
hormone secreted from skeletal muscles, upregulated UCP-1 expression in 3T3-L1
adipocytes at the basal state and induced browning of subcutaneous fat pads when
injected into the mice (Zhang et al., 2014). However, whether Irisin enhances ISOstimulated UCP-1 activation and thermogenesis has not been reported. It is worthy of
noting that naringenin exposure during differentiation increased PRDM16 mRNA and
suppressed mRNA expression of Meox-2, and IGFBP3, similar to those of Rosi at the
basal state, suggesting that naringenin promotes the acquiring of some of the
characteristics of brown-like adipocytes induced by Rosi. However, it remains to be
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determined whether naringenin induces development of functional brown adipocytes in
vivo.
To explore the mechanisms by which naringenin promotes ISO-stimulated
thermogenic activation, we examined the effects on naringenin on the signaling events
downstream of ISO. It has been reported that adrenergic activation in brown adipocytes
induces cAMP accumulation, leading to PKA activation, which indirectly leads to
phosphorylation and activation of p38 MAPK. Activation of p38 leads to upregulation
and activation of PGC-1α, coactivator of PPARγ on the PPRE site in the promotor of
UCP-1 gene, leading to UCP-1 transcription (Cao et al., 2004; Cao, Medvedev, Daniel,
& Collins, 2001). Our results indicate that naringenin enhanced PKA activation
downstream of ISO to a level that is similar to that of Rosi. Moreover, naringenin
exposure induced a higher level of phosphorylation of p38 at the basal state and further
enhanced phosphorylation of p38 stimulated by ISO. We also show, for the first time,
that Rosi also enhanced basal phosphorylation of p38 to a much higher level and further
maintained a strong phosphorylation of p38 stimulated with ISO. Phosphorylation of p38
MAPK leads to upregulation of PGC-1α transcription and enhanced interaction between
PGC-1α and PPARγ, leading to UCP-1 transcription in response to ISO (Cao et al.,
2004; Cao et al., 2001). Our results demonstrating enhanced upregulation of PGC-1α
mRNA and increased of PPARγ transactivation by naringenin are consistent with the
effects of enhanced phosphorylation of p38 by naringenin. Furthermore, we show that
inhibition of PKA or p38 suppressed ISO-stimulated UCP-1 activation. Together, these
results suggest that the enhancement of ISO-stimulated thermogenic activation by
naringenin is mediated through PKA/p38 MAPK pathways (Figure 23).
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In conclusion, we have demonstrated that naringenin at 10 µM enhances ISOstimulated UCP-1 activation and thermogenesis in 3T3-L1 adipocytes, possibly through
enhancement of PKA/p38 MAPK pathways downstream of ISO. Our results suggest
that naringenin may be beneficial in promoting activities of functional brown adipose
tissue in vivo. Further studies of naringenin in the development of functional brown
adipose tissue and promote thermogenesis in vivo are warranted.
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4.7 Appendix
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Figure 17 Effect of naringenin on mRNA expression of brown adipose specific
markers
3T3-L1 preadipocytes were induced to differentiation in the presence of various doses
of naringenin (NAR, 0, 5, 10 µM) for 7 days. On day 7, matured 3T3-L1 adipocytes were
treated with or without isoproterenol (ISO) for 6 h. Total RNA was extracted and mRNA
expression of target genes were quantified and normalized by 36B4. The relative mRNA
expression was expressed as fold of changes compared to that of DMSO control (-, set
as 1). (A) mRNA expression of brown adipose specific markers UCP-1, PGC-1α,
PRDM16, novel brown marker Meox-2, and white adipose specific markers IGFBP3 at
basal level; (B) mRNA expression of thermogenic markers UCP-1 and PGC-1α at ISOstimulated level. Rosiglitazone (Rosi) was used as a positive control. Data were
presented as mean±SE (n=3). *, significantly different from the DMSO controls (-) with
p<0.05.
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Figure 18 Effect of naringenin on mitochondrial respiration in isoproterenol
induced 3T3-L1 adipocytes
3T3-L1 cells were differentiated in the presence or absence of naringenin (NAR, 10 µM)
until day 7. The cells were then sub-cultured in 24-well XF assay plates overnight,
followed by stimulation of isoproterenol (1µM) for 6 h. Real-time measurements of
oxygen consumption rate (OCR) coupled with mitochondrial stress tests were
conducted. The mitochondrial complex inhibitors were injected sequentially in the
following order: oligomycin (1 µM), FCCP (0.75 µM), antimycin A/rotenone (1 µM each),
and three readings were taken after each inhibitor. (A) OCR from proton leak, (B)
coupling efficiency, (C) maximal respiration, and (D) ATP production. Rosiglitazone
(Rosi) was used as a positive control. Data were presented as mean±SE (n=3). *,
significantly different from the DMSO controls (-) with p<0.05.
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Figure 19 Effect of naringenin on PKA activation
3T3-L1 cells were differentiated in the presence or absence of naringenin (NAR, 10 µ M)
followed by costimulated with or without isoproterenol for 6 h. Total cell lysate was
prepared and PKA activity was measured as described in materials and methods.
Rosiglitazone (Rosi) was used as a positive control. Data were presented as mean±SE
(n=3). *, significantly different from the DMSO control (-) with p<0.05.
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Figure 20 The effect of naringenin on the phosphorylation of p38 MAPK
3T3-L1 cells were differentiated in the presence or absence of naringenin (NAR, 10 µM)
until day 7 followed by isoproterenol treatment for different times as indicated in the
figure. Total cell lysate was prepared and analyzed by Western blot with specific
antibodies against phospho-p38 MAPK and total-p38 MAPK. Rosiglitazone (Rosi) was
used as a positive control. The experiments were performed 3 times. Results from a
representative experiment was shown here.
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Figure 21 Effect of naringenin on PPARγ and PPRE transactivation
3T3-L1 preadipocytes were transfected with (A) PPARγ-gal4 and (B) PPRE
transactivation reporters. Cells were treated with or without naringenin (NAR, 10 µM) for
18 h in 0.25% FBS containing DMEM. Cell lysate was prepared and reporter gene
assay performed. Rosiglitazone (Rosi) was used as a positive control. PPRE
transactivation normalized by total protein concentration is presented as fold of that of
the control (set as 1). Data were presented as mean±SE (n=3). *, significantly different
from the DMSO control (-) with p<0.05.
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Figure 22 Regulation of UCP-1 gene expression by pharmacological inhibitors for
PKA/p38 MAPK signaling pathway
3T3-L1 cells were differentiated in the presence of naringenin (NAR, 10 µM) or
rosiglitazone (Rosi) until fully differentiated. The differentiated cells were pretreated with
PKA inhibitor H-89 (20 µM), SB203580 (10 µM), or DMSO for 1 h followed by
isoproterenol (1 μM) treatment for 6 h. Rosiglitazone (Rosi) was used as a positive
control. mRNA expression of UCP-1 was evaluated by semi-quantitative RT-PCR. The
relative mRNA expression was normalized with 36B4 and expressed as fold of the
vehicle value (set as 1). Data were presented as mean±SE (n=3). *, significantly
different from the DMSO control (-) with p<0.05.
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Figure 23 Schematic diagram of activation of β-adrenergic receptor-stimulated
signaling pathway and naringenin effects
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CONCLUSION AND FUTURE DIRECTION
In this dissertation, it has been reported that (1) mRNA of selected PRRs and
inflammatory cytokines/chemokines are upregulated in the BAT of both DIO and ob/ob
mice; (2) activation of PPRs induces activation of NF-κB and MAPK signaling pathways,
leading to upregulation of the proinflammatory genes MCP-1, IL-6, RANTES, and TNF-α
in mature brown adipocytes; (3) activation of PRRs suppresses UCP-1 expression,
leading to decreased mitochondrial respiration and thermogenesis in mature brown
adipocytes; (4) chronic activation of PRRs reduces adipogenesis and suppresses
expression of brown-specific genes in both classic brown adipocytes and multipotent
stem cells, suggesting that chronic activation of PRRs negative affect BAT
development; lastly, (5) naringenin, a citrus flavanone, enhances thermogenic activation
in isoproterenol-stimulated 3T3-L1 adipocytes through PKA/p38 MAPK activation.
Our results suggest that PRR-mediated inflammation in brown adipocytes may
be potential targets to regulate BAT development and function for obesity treatment and
prevention. Dietary bioactive compound naringenin may be beneficial in promoting
functional BAT, contributing to energy expenditure.
In the future, the studies of the role of PRRs in brown adipose inflammation in
vivo using the animal models would be needed to confirm the results using the cell
culture models reported in chapter I and II. Selected PRR knockout animal with high fat
diet could be used to determine the role of PRR in brown adipose inflammation and
obesity. Since specific PRR knockout mice have been used to examine body weight,
plasma inflammatory cytokines, and adipose inflammation in WAT, BAT inflammation
and function can be examined in the same animal models. Moreover, these models can
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be used to screen dietary bioactive compounds with anti-inflammatory properties for the
activities to reduce BAT inflammation and promote BAT development and function.
Furthermore, the effects of naringenin in promoting thermogenic activation in white
adipocytes should be tested and extended in the animal models. Successful completion
of naringenin studies in these preclinical models will provide justification to test the
efficacy of naringenin in promoting functional BAT in human clinical trials.
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